Official source · cited records
PubMed, page 3
2,673 public records from PubMed that PeptideScanner profiles or records cite, newest check first. Inclusion is not a source rating, endorsement, or claim of comprehensive monitoring.
Page 3 of 6
Official source · 2,673 cited records
- Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis. · retained source version 1:2019-12-10:current:ba605561a0978eaa8959d5c02b776b217c53b9b170b554ee429b22d8178da4d5 ↗Source checked November 15, 2026
- Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis. · retained source version 1:2019-12-10:current:68bd2ce3fe0c1d044d44bba4ac22a9ed8e6c0c0c0da10999ae9c4ae52c0f9e64 ↗Source checked November 15, 2026
- Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2-4 Years with Rett Syndrome. · retained source version 1:2026-08-17:current:396ace5b868f7f3724f4f2c5943205eea5dcd4908af111273cb21c140e0a1dd3 ↗Source checked November 15, 2026
- Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. · retained source version 1:2018-10-25:current:cb925afc1222f2e772dd0733802c4e71ae519a0aec6ac20d1003478df32c7773 ↗Source checked November 15, 2026
- Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study. · retained source version 1:2026-06-03:current:ecf185f4e6b8f6edd4b12dc0a9c8680ea6288f5baa7a162bae9cdc517de5e9e8 ↗Source checked November 15, 2026
- Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients. · retained source version 1:2026-01-28:current:f3a312f083857450074c16fda6ee7c615d60075ad13337de2c623cfe1e04db2a ↗Source checked November 15, 2026
- Present and evolving role of eptifibatide in the treatment of acute coronary syndromes. · retained source version 1:2018-12-01:current:a175d7e651205707710625af3476e6abed8636a736afa9ebfda6463473f4da5a ↗Source checked November 15, 2026
- Prolonged use of eptifibatide as a bridge to maintain drug-eluting stent patency in a patient receiving extracorporeal membrane oxygenation. · retained source version 1:2018-12-19:current:5e1c31d1e479c9ad160605f57c3ffdad39871e70ac7488201ccc06067865a253 ↗Source checked November 15, 2026
- Prophylactic Intra-Arterial Eptifibatide in Stent-Assisted Coiling and Flow Diverter Treatment of Cerebral Aneurysms: A Single-Center Retrospective Analysis. · retained source version 1:2025-11-15:current:b598b31ba1fd8a799a3ba3ef236a0c6c998f8294311efc0dc329beaef558a78c ↗Source checked November 15, 2026
- Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation. · retained source version 1:2026-11-09:current:112283fc425c265679202a06db1d697db4e6f0b259fb61c45ea2089ae25297c6 ↗Source checked November 15, 2026
- Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder. · retained source version 1:2020-06-26:current:9a310767e82a36537279a2bb4f116d7fe0dbe73d107ffce87069af843db4b07f ↗Source checked November 15, 2026
- Provocative tests with Kisspeptin-10 and GnRH set the scene for determining social status and environmental impacts on reproductive capacity in male African lions (Panthera leo). · retained source version 1:2022-11-30:current:7ef9683ed25a65ba54e24a26758409cbad2f583931deedeea5bce65f52b4329f ↗Source checked November 15, 2026
- Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies. · retained source version 1:2026-03-12:current:8474132dd9df1d64999070712e0cfe872875729c9a82d840bbd9bc53478a9071 ↗Source checked November 15, 2026
- Quality of life and lived experience of patients with short bowel syndrome treated with teduglutide and weaning off home parenteral nutrition: a qualitative analysis of patient diaries. · retained source version 1:2025-10-21:current:076ff4d0de7af0b81b248f678ac1b391229358f2692248d537dc195c948d458d ↗Source checked November 15, 2026
- Radioimmunoassay of ganirelix in plasma or serum. · retained source version 1:2019-11-01:current:5f6b2ab9fdb0c3bab443257e5a2024daff3017747e478a5f826ec484b4b50b33 ↗Source checked November 15, 2026
- Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5. · retained source version 1:2016-11-02:current:c21fff07bdd555c329a2b005bb17ac016288dd9e5aff926243132d8821bf228c ↗Source checked November 15, 2026
- Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. · retained source version 1:2022-07-16:current:72492b30411d7d89307e025851cc6b8fa3be1294cfb8d5192cf03509a9f56b25 ↗Source checked November 15, 2026
- Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis. · retained source version 1:2022-01-06:current:c591d3e8507e9a57061c0ca8690907eb4bc6cecb2d01f3ddf06fdd6a41a0b1eb ↗Source checked November 15, 2026
- Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. · retained source version 1:2024-12-19:current:2bc2c65af9e7ade66cda8de0f3c34f0b9f9a36c26282a9ccd7f089339b3d5bce ↗Source checked November 15, 2026
- Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly. · retained source version 1:2024-08-15:current:e2bacc5903e34709c3c5c3a00c7227d4a7d789bd9a56f3ff0fa8c9d9f3538acf ↗Source checked November 15, 2026
- RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY. · retained source version 1:2022-04-22:current:6fc75dafb54eaa433e059d451d35e6ab7da99b541e3f6730aeba8c65bf6df65a ↗Source checked November 15, 2026
- Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina. · retained source version 1:2026-09-10:current:0b416d0cd0c85acc14c2bd96cccc75d8e63a3ad297d6b4bde8a46d15959b0cae ↗Source checked November 15, 2026
- Real-life data on pasireotide in monotherapy or combined in active Cushing's disease. · retained source version 1:2025-12-03:current:129259ecbb96e734d111b16639cb16108a357fc19e0a65caa21f1bf942778009 ↗Source checked November 15, 2026
- Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study. · retained source version 1:2026-02-08:current:cf2e44e296180bda702a7653e530292bf6565236119102d738f30e71419c2f5e ↗Source checked November 15, 2026
- Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide. · retained source version 1:2026-10-01:current:f347d406e0c82aa7df48455f585f12b1ea9a1ea2be56e637fe93892c101d74ad ↗Source checked November 15, 2026
- Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore. · retained source version 1:2023-12-06:current:040745c29c2d776e690ca4886ad7bff3ea7d497fc735b1b5039c9ee1d28a65c6 ↗Source checked November 15, 2026
- Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study. · retained source version 1:2025-04-28:current:6d772ff715faa1a774dfc7f8465cc7c14643e622a074c7fbf9b72ef64c6ec2f9 ↗Source checked November 15, 2026
- Real-world off-label use of icatibant for acute management of non-hereditary angioedema. · retained source version 1:2021-05-31:current:2261681d2b3a96bd39ee09bb9d0f191a0117f8b33e1075825079001aaa463512 ↗Source checked November 15, 2026
- Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States. · retained source version 1:2026-09-26:current:2377f0792967d0b3e7d4a325ae00a1a72c704fd9628695cf1729a7a2d29c3b8a ↗Source checked November 15, 2026
- Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. · retained source version 1:2021-01-05:current:114f4668942b8ac923e10c9bc91227d648bb473cbde5909e6a585313a621ea27 ↗Source checked November 15, 2026
- Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome. · retained source version 1:2024-07-16:current:cee7b36fb0bb7148b9beb111edc08009a5f043439c354a784952ee52e0b4d5b8 ↗Source checked November 15, 2026
- Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study. · retained source version 1:2019-05-13:current:ecab6df949bf1a44c33bf0a83c420642a07249f9e86ffa918512f74416576a5a ↗Source checked November 15, 2026
- Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia. · retained source version 1:2026-10-12:current:1ce7771f657969e60cab065566dadadb988be8f61fba289cb28c2a551ecc4227 ↗Source checked November 15, 2026
- Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy. · retained source version 1:2022-09-12:current:6ae696854ed6a9231294c347627a3b419dec628429353c355ced9a0f4b3ffbdf ↗Source checked November 15, 2026
- Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. · retained source version 1:2026-11-08:current:855d8c189e597b76dc46c231025633a128346fd31bdd51ac459d0e0512632ee4 ↗Source checked November 15, 2026
- Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance. · retained source version 1:2025-07-28:current:e543243b47e724d1b9d867ce37632c2b56b45ff672847fd671896faef32b0037 ↗Source checked November 15, 2026
- Resting state functional connectivity in paedophilic disorder and degarelix treatment. · retained source version 1:2026-08-14:current:c2b6c5686d4056539b6219afcdebd24e59cc635c423383db6870af5186a5f40f ↗Source checked November 15, 2026
- Rett syndrome and real-world treatment patterns of trofinetide in the United States. · retained source version 1:2026-06-13:current:3e1fd975fc09cebfd514d7e54518476584fd4ce39bf183b2887c47b93cb2defd ↗Source checked November 15, 2026
- Review of icatibant use in the Winnipeg Regional Health Authority. · retained source version 1:2024-03-30:current:0ee69679bfc0962869b09e7898bf01ca6ad142eb73b039e5956dd3dc3917bcf2 ↗Source checked November 15, 2026
- Role of Bivalirudin for Anticoagulation in Adult Perioperative Cardiothoracic Practice. · retained source version 1:2022-05-31:current:7d4f755848ea6f1cada57144d0189ad434c81cb224b859ceeeb54d5b9a0f9a46 ↗Source checked November 15, 2026
- Role of oxytocin and vasopressin in alcohol use disorder. · retained source version 1:2026-06-21:current:6f39dca88f48b1894eb2f5ebe8f87a21259882a05e5971731f70208a8d9b26cc ↗Source checked November 15, 2026
- Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation. · retained source version 1:2024-03-21:current:2505a6bb5b903b3826dbfa76f7fa6ed5533ba8520e5fecb629c65663dc92270c ↗Source checked November 15, 2026
- Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence. · retained source version 1:2021-05-06:current:b85a5a020030ec51c7fd1e94ed366e72f17623d4da5b2521876208fe3db1fb6a ↗Source checked November 15, 2026
- Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock. · retained source version 1:2019-11-11:current:6f39b10fe2207f00de55c611398e184da8af699affec349c0cabc56de55f90d4 ↗Source checked November 15, 2026
- Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer. · retained source version 1:2022-12-07:current:01814f5a48c0c3afe3358d22d648566044f975ccd1a71d3ce42736bee29bf954 ↗Source checked November 15, 2026
- Roles of Goserelin in Gynecological Disorders. · retained source version 1:2026-08-13:current:930f5b5e431ce260e4e55270cba34841899e2e4f507bad86e34ebb1266e9e88e ↗Source checked November 15, 2026
- Second line treatment of acromegaly: Pasireotide or Pegvisomant? · retained source version 1:2022-12-22:current:da181b76d59a089c0d9a3dfd2087412afec7954fe4720cc2dbfd26f046582a7b ↗Source checked November 15, 2026
- Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases. · retained source version 1:2022-12-07:current:5acf7568883220da5abfee1da0efafb612fb730361911c7b5165e373db1c9b7d ↗Source checked November 15, 2026
- Serum thymosin alpha 1 levels in normal and pathological conditions. · retained source version 1:2019-06-25:current:e86d24d6c7066692e2de233a75fb5d7d2b8b311724592a2a154a889f0dffbd00 ↗Source checked November 15, 2026
- Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide. · retained source version 1:2025-05-15:current:63d9e9ce139a9f6a6123ff0be47d09e3aa84f89104ba1769ad3095e0ea4cf3d3 ↗Source checked November 15, 2026
- Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure. · retained source version 1:2026-01-27:current:27067eec4a7da04168534dbbb3ef16cc66453b053893ec69e14dfe4fd1444226 ↗Source checked November 15, 2026
- Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis. · retained source version 1:2025-09-17:current:49d37fef12d96160c5ceeb37578b29e37a3db1428507107f23c0681358e73ef7 ↗Source checked November 15, 2026
- Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer. · retained source version 1:2024-03-14:current:c9c9e7dbdbe0679cb79fec9fa9690e1b66765dd069b11078e572c8cd70da286b ↗Source checked November 15, 2026
- Structural basis for Kisspeptin-10 selectivity toward KISS1R: computational insights. · retained source version 1:2026-11-12:current:9044564bf0b334a5ac30474bfb2355348637df858d4c3ddb9ac80e9359454be7 ↗Source checked November 15, 2026
- Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures. · retained source version 1:2022-12-07:current:9c1a28a71ec62cfe2c3ecd4871734a3465f0ba2ced0accae7fba3ad977dd1da1 ↗Source checked November 15, 2026
- Synthesis of Diastereomerically Pure Cetrorelix Acetate by Using Fmoc Solid-Phase Peptide Synthesis (SPPS) Strategy: A Commercially Viable Approach. · retained source version 1:2026-01-27:current:695b58a1f5b2d08d6b322a052811ef5924435be61f7a2c5a5f81937d76c40405 ↗Source checked November 15, 2026
- Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity. · retained source version 1:2018-12-02:current:b75ba4cddc5ea741f4d546fd17f8d769c016d487d5335730bbb3ff487dbeb35d ↗Source checked November 15, 2026
- Systemic delivery of melanotan II through the ocular route in rabbits. · retained source version 1:2006-04-13:current:4a1cc225ada909cedc8012787127ebacfb569412df52646adb986837090f9931 ↗Source checked November 15, 2026
- Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM. · retained source version 1:2022-07-06:current:0aefe5ae5520aabdd588465d60683d8027834c7c5b46f139052d366468425d78 ↗Source checked November 15, 2026
- Teduglutide for short bowel syndrome. · retained source version 1:2020-09-28:current:db06e07faf6b0d422cb6fddb673ae2675d4f2b7d9d0fbb8f3f0525f2aeeffc51 ↗Source checked November 15, 2026
- Teduglutide for the treatment of short bowel syndrome: a double-edged sword? · retained source version 1:2023-06-16:current:cd0c373d9e98f378ded7b9cd90ce458726b000caefc3638219a489ef8560975f ↗Source checked November 15, 2026
- Teduglutide for the Treatment of Short Bowel Syndrome. · retained source version 1:2019-11-20:current:6d7cb4834169b70b32197001d8df70a9b89dd7a5d642a0ab4f3cee67bf33e840 ↗Source checked November 15, 2026
- Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome. · retained source version 1:2020-05-01:current:35b4b38f028dd5a6656e0505e1d982ad7c82911671430df4f693c0f54d61cfe2 ↗Source checked November 15, 2026
- Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP). · retained source version 1:2026-01-27:current:f3eeda60c1891ba8ba1a73a0b70c05c9bd8a61d4793b4e824f0cf5ccac964d27 ↗Source checked November 15, 2026
- Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis. · retained source version 1:2021-07-08:current:f8aba93b5c9498e888677fdbf652416dcbf83a351c796a325199b22b3cafb30e ↗Source checked November 15, 2026
- Teduglutide treatment during breast feeding in a patient with intestinal failure: a case report. · retained source version 1:2025-08-09:current:efbc9b34b4e34640ff1ff94eb648b27e5642fe48d4486232a372a600c137fc2b ↗Source checked November 15, 2026
- TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW. · retained source version 1:2024-05-24:current:d81451a0812db3a3cde86fbb00d369b509d93319fdb270919f5e0403f3d243f2 ↗Source checked November 15, 2026
- Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-on-Chronic Liver Failure. · retained source version 1:2026-08-11:current:01b871ef5dc97d6bda2e5f333451a653783f5b5c1e76798a27c37eff874b5994 ↗Source checked November 15, 2026
- Terlipressin for hepatorenal syndrome. · retained source version 1:2025-06-26:current:8f0183b154e99a1454109ecfa957a2e0c7a819c6cb73fef04ebe16649421016c ↗Source checked November 15, 2026
- Terlipressin for hepatorenal syndrome. · retained source version 1:2025-07-29:current:b4cd887c11ad8089bea1623e1c7e260726ddbd475ad66fcd97c670243fc681a4 ↗Source checked November 15, 2026
- Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence. · retained source version 1:2020-03-24:current:8833ccc3cb8b7818cfc56be77634af89703feced753285e499c0a110a554932d ↗Source checked November 15, 2026
- Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. · retained source version 1:2025-06-26:current:07fb3f94204ab005f9678c5feeee7106fd45e7b1a379e4492ed079479706ea19 ↗Source checked November 15, 2026
- Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI). · retained source version 1:2026-08-20:current:52510674bdeb961d3902e09f6e8bda2dc8870668d737d4f83ab71a55dad1df6a ↗Source checked November 15, 2026
- Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. · retained source version 1:2026-05-18:current:3797e8cc040e5316cd51a9b083c641b8d7b69838707d7623fbf0d728a5b881c8 ↗Source checked November 15, 2026
- Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation. · retained source version 1:2026-01-27:current:867f20f834034d43bc488f252ce56999d5ba018b2c06987aad2cccc8cee1a1b2 ↗Source checked November 15, 2026
- Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis. · retained source version 1:2020-09-30:current:f4f2986f6776b6d1b517c0c46e80b438d4257d17cdba2dc65934f720064511f4 ↗Source checked November 15, 2026
- Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome. · retained source version 1:2025-06-23:current:bad9fa5ef06058966eda541817c7782c8eb15ccc70d2491c2ccfa44b15c5ad19 ↗Source checked November 15, 2026
- Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. · retained source version 1:2024-09-20:current:9d15edddc5f758faf4b045e92b4e7b711d00340531b5b960f8a8d9e94ac37cde ↗Source checked November 15, 2026
- Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. · retained source version 1:2026-07-24:current:ad0c3b1cf9096e39f738eb7f4769729d1290b536938f2be06a0c2e628d545711 ↗Source checked November 15, 2026
- The Antibiotic Peptide Daptomycin Functions by Reorganizing the Membrane. · retained source version 1:2026-10-10:current:ee1e0bba6d44f7f7a6c3cb906aa41762ae209b51861bd7f409b68533ff31aaa1 ↗Source checked November 15, 2026
- The Application of Terlipressin in the Management of Ascites in Liver Cirrhosis: Current Status and Prospects. · retained source version 1:2024-12-05:current:738fbf3bff925eec9b7d14b765546f824880030a3d9ba0426a49e2568b503c6c ↗Source checked November 15, 2026
- The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. · retained source version 1:2026-05-18:current:4e0c11947bf6576c6855c9dbec31a8adbd2c788782e7c84857151578855ed1db ↗Source checked November 15, 2026
- The first preparative solution phase synthesis of melanotan II. · retained source version 1:2021-10-20:current:69d2a3410e2b15fc51aba6dd5e9ee2e53317926c573ce99efc7e2e394d738c55 ↗Source checked November 15, 2026
- The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis. · retained source version 1:2021-09-29:current:cb0299d3d403dd2956ec87ab3b2ee8abc579af689fa9f5bf75e6d262400c9994 ↗Source checked November 15, 2026
- The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis. · retained source version 1:2025-05-22:current:19e50c0b3ce5209eda853c39df424dda4aef27256d977c6567be01a45fa82a15 ↗Source checked November 15, 2026
- The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant. · retained source version 1:2019-07-23:current:de7faaa3674ac9361b01164921ed8860cf13274fa20a73d24540786dd9b310a9 ↗Source checked November 15, 2026
- The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial. · retained source version 1:2021-10-21:current:235ee5e0f3bf4cb1ece50ed38c33d6f4f52ddbb444627a43209f18c4b266f306 ↗Source checked November 15, 2026
- The LHRH antagonist cetrorelix: a review. · retained source version 1:2019-05-13:current:30bc4d53d0f71b22aeabb14dd7b2364d7943fb66c791c4c7214f4e3d516eb011 ↗Source checked November 15, 2026
- The Role of Cathelicidin LL-37 in Cancer Development. · retained source version 1:2022-12-07:current:fcf3d63d0d66451a2f5d5683e8e08cf1a553bf981f12cdbb66451d938ae38a3f ↗Source checked November 15, 2026
- The Role of Oxytocin and Vasopressin in People with Borderline Personality Disorder: A Closer Look at Adolescents. · retained source version 1:2024-12-13:current:e0c7eda978213429dcef9de38cee00ea173edce90f6f910ddd90a4a5ba128f4b ↗Source checked November 15, 2026
- The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR. · retained source version 1:2024-07-10:current:acd0e77b9a2230f664868a9b81e4622825abdff17342faa482bb71f9d8f19f48 ↗Source checked November 15, 2026
- The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease. · retained source version 1:2022-12-07:current:1ba9bb0eeec7157997c852eb0823891a4e77182050f9651c9337002004855052 ↗Source checked November 15, 2026
- The unregulated use of melanotan-II is of public health interest to Australian dermatologists. · retained source version 1:2019-03-14:current:b62d70a3bff6ded6d8a807ec5ae5b1e5eda025c161ab9f4d4ac3239e6a74cbb5 ↗Source checked November 15, 2026
- The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite. · retained source version 1:2021-08-02:current:9d6c49c9ba0ef2cd86d81eca8bd263dd8c6b3c37f6c93562a277fa564d2011eb ↗Source checked November 15, 2026
- The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices. · retained source version 1:2020-12-09:current:c948d0150dedffedae552b83098c79e7fe4a249993fb4dab5d579d20635120a6 ↗Source checked November 15, 2026
- The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study. · retained source version 1:2018-12-01:current:1a09d3989bead57725fc728ec7a1d60b9d00b0ea550c6acd1153d2fd71c7e5ce ↗Source checked November 15, 2026
- The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review. · retained source version 1:2026-11-04:current:bd8c6f911737d7c40d7174311df1225c510852d8dce060411db3111d8f631376 ↗Source checked November 15, 2026
- The vasopressin system as an immunoneuroendocrine therapeutic target in inflammatory conditions. · retained source version 1:2026-09-08:current:0caca9ccd79a352d14b8f22e49601d8504e5a01e3bef25cd33b174c86a67d761 ↗Source checked November 15, 2026
- Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis. · retained source version 1:2024-11-07:current:c8be215fce49bd0c60a8933a626a92fe26ffba126d4b8a791dab684614845285 ↗Source checked November 15, 2026
- Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial. · retained source version 1:2026-11-03:current:14ad108ef36f98cacb7a0152d36f3238bb733c16bca683c2b27ddb928e6a9646 ↗Source checked November 15, 2026
- Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B. · retained source version 1:2018-12-01:current:0f714efb558b2c38a29205517b8a9a0fc5bae1ac7fb6817d38101bd2f5d1e307 ↗Source checked November 15, 2026
- Thymalfasin for the treatment of chronic hepatitis B. · retained source version 1:2019-11-09:current:721edf86da035d59960222b1ac5bb422d5fa3fbfe395f219fa602500019d0061 ↗Source checked November 15, 2026
- Thymalfasin for the treatment of chronic hepatitis C infection. · retained source version 1:2018-12-03:current:bccf74193a359ee75f2303ec02088bdb9a97e40beee7000e5602752c5469333d ↗Source checked November 15, 2026
- Thymalfasin in the treatment of hepatitis B and C. · retained source version 1:2026-01-28:current:9c7e9805ba601906e0e796df14675ba76015a25b36580c30c2847d6f1085ca52 ↗Source checked November 15, 2026
- Thymosin alpha 1 and HIV-1: recent advances and future perspectives. · retained source version 1:2018-12-02:current:3fa552d98ba79ef3a09936d5d3224b42e29c37ef513b8496b672c71219036e96 ↗Source checked November 15, 2026
- Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries. · retained source version 1:2018-12-01:current:16def7529435b9d2cda3da4fbb0700aa0a3dbb6697980dad7ed5f785e58f1098 ↗Source checked November 15, 2026
- Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. · retained source version 1:2018-12-01:current:ef2debece00452abe1176a215d8bac0538153ba20e43ed14123b15de6ad1ddab ↗Source checked November 15, 2026
- Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. · retained source version 1:2024-12-16:current:7ec48cc3db08aab3eb72022a99167f50301ea021259fe1ef0d1c93a6dc778825 ↗Source checked November 15, 2026
- Thymosin alpha 1 treatment for patients with sepsis. · retained source version 1:2019-06-25:current:4a89748ecabb725ac303127ec4e8099ef7ec603f248f09a7158c7de5af54a272 ↗Source checked November 15, 2026
- Thymosin alpha 1: A comprehensive review of the literature. · retained source version 1:2020-12-29:current:96f371610863b6832c5115cbae5800623e3cf9342dceaaf04af184bc9285d9ef ↗Source checked November 15, 2026
- Thymosin alpha 1: past clinical experience and future promise. · retained source version 1:2026-01-28:current:219ebe73a316eb4e41acbca4fc5a64cb4133a5cc476ee2644fcab8664a089348 ↗Source checked November 15, 2026
- Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role? · retained source version 1:2018-12-01:current:b8e16df877b207e58840cfc81cb893820fe12e45e32226958cf53a1ac854ec6a ↗Source checked November 15, 2026
- Thymosin alpha-1. · retained source version 1:2019-02-22:current:73b82868b9259b13a4df4593554042a6a29d09306e94b76b54fa72f5f2452f21 ↗Source checked November 15, 2026
- Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer. · retained source version 1:2018-11-30:current:0844747aad755d345f761e83816fa916d83c3f3a0eed38dd581442662c36ef90 ↗Source checked November 15, 2026
- Tibial bypass salvage with eptifibatide in a patient with thrombocythemia. · retained source version 1:2020-09-29:current:1216cafdbae1c57846c4f0d05e3dba205bc167c615a159ef2e7a65fd77469167 ↗Source checked November 15, 2026
- Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial. · retained source version 1:2026-05-22:current:bee8869c01716f113d554666750b6aed96d1cbbaba250e6a90ee37da004c6a11 ↗Source checked November 15, 2026
- Tipping the balance in favour of degarelix for ADT. · retained source version 1:2021-10-21:current:43be7bd4ccae6a45e40c29a9f5bb6981d8295988e07b9b95b267556160230fe0 ↗Source checked November 15, 2026
- Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema. · retained source version 1:2013-11-21:current:d04871fd14b3780d2403642af30daae066ee35351a416d9564c84c58df7fef69 ↗Source checked November 15, 2026
- Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1. · retained source version 1:2018-12-01:current:fcd077bef0ee56aa3ff03b18a914df8fbe1844505a44eb243c4bf706271734f2 ↗Source checked November 15, 2026
- Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy. · retained source version 1:2013-11-21:current:5281f952c7ccbf3bf20274246fc6be593e624646269f04516c5914985a8a01b3 ↗Source checked November 15, 2026
- Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant Enterococcus faecium: A Focused Review of Linezolid and Daptomycin. · retained source version 1:2020-12-25:current:861a010df1642c5e31b5818abd1062fa7f6369625f33a5b5582751ca8db34891 ↗Source checked November 15, 2026
- Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). · retained source version 1:2014-11-20:current:fc386cafb80811bdcf618f6eed407774fac4e11db8a131864851154f454e3b35 ↗Source checked November 15, 2026
- Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. · retained source version 1:2022-03-09:current:fa88dfa4d63cf149d5cb955f57737e6529d9995b99f69f0b33d9efa89845a52e ↗Source checked November 15, 2026
- Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ? · retained source version 1:2019-12-10:current:3eea5e65525d5e6ac562cab1ab4229b6ed9d32b45422093873a7089b0ac8ad51 ↗Source checked November 15, 2026
- Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. · retained source version 1:2024-03-26:current:bd82592c1ecff67f001e44658e7d0feb512158e583a104ebd5100b5e60998dcd ↗Source checked November 15, 2026
- Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. · retained source version 1:2019-05-12:current:41144fae289a0d4b7b3737394614f8549281f32720d90923a11ddee89d652464 ↗Source checked November 15, 2026
- Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix. · retained source version 1:2019-05-12:current:3f2f0f0ad015d8999d62a0328014bb790104899eee37df5d82c2abdad64872ca ↗Source checked November 15, 2026
- Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis. · retained source version 1:2024-05-16:current:f0c75ce95f3d3026dfd1a0a546146741a992dfaf5d091833a011b7710e5046a8 ↗Source checked November 15, 2026
- Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study. · retained source version 1:2026-01-28:current:497f1622e2164eb540552f4fa6383b1d6e191db70cc280d2fe8481048b7958f5 ↗Source checked November 15, 2026
- Triptorelin depot for the treatment of children 2 years and older with central precocious puberty. · retained source version 1:2019-02-21:current:da00b0d382a25f050c3bc5b9449557cd1051e6076cf478ad8c4d6bec1d3b1ff4 ↗Source checked November 15, 2026
- Triptorelin embonate (6-month formulation). · retained source version 1:2022-07-16:current:66dcd2ce6aa8f68ebab6ed9dd28f926e6a81595bc536f0d9d41fa7e00554cf41 ↗Source checked November 15, 2026
- Triptorelin embonate: a 6-month formulation for prostate cancer. · retained source version 1:2018-12-01:current:54dac415a73e06627ac565dfe3b2268974067d20923d8ff6ce940376d92dca3d ↗Source checked November 15, 2026
- Triptorelin for the treatment of endometriosis. · retained source version 1:2018-12-02:current:5f68ce9f6c7d03d3527549f7befb775f7e67332de565b236c97cfca078db206c ↗Source checked November 15, 2026
- Triptorelin in the management of prostate cancer. · retained source version 1:2018-12-02:current:f507a7747ec847ac72e3dcf3f8dafda4344786a30ca64f0244e1f764d2890e32 ↗Source checked November 15, 2026
- Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer. · retained source version 1:2026-01-27:current:50d8a9a3c9128807e04804c8694e156899610b5c4104940561175a6597ebc51a ↗Source checked November 15, 2026
- Trofinetide (Daybue) for Rett syndrome. · retained source version 1:2024-07-15:current:46a3d1c0c2e8d6ae19f1e0cc145ee7744994f9be9c706196b4db399a15d5a6b7 ↗Source checked November 15, 2026
- Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. · retained source version 1:2025-12-01:current:1e6945877def3b5d9b1b1c0b6a13daad9cb9b545e88cbe3f9b62652234937d62 ↗Source checked November 15, 2026
- Trofinetide treatment for Rett syndrome: Lessons to learn. · retained source version 1:2026-06-04:current:803b92913ad9bc5c426197cded4a94d759a4ad8c00de01eed477354776164b93 ↗Source checked November 15, 2026
- Trofinetide-a new chapter in rett syndrome's treatment. · retained source version 1:2023-12-02:current:a2366d99985d4039de7b1916f65f6e36c742dca533ba6503f6d1fe0a5d687c3d ↗Source checked November 15, 2026
- Trofinetide: a pioneering treatment for Rett syndrome. · retained source version 1:2024-10-03:current:1fbe8c7a869b6669d32e22ccf5af1fc270c4cc578c503ef733dd193dff388802 ↗Source checked November 15, 2026
- Trofinetide. · retained source version 1:2023-10-24:current:b6a89c9fbdd66fbaac6f144bad6de64b904f9dff1f9c4dde63f9c6b89adea4af ↗Source checked November 15, 2026
- Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. · retained source version 1:2018-11-13:current:6acd0535fb5d913707848ea8b91b8b4e1cba735f00367e59419ec1068be86c07 ↗Source checked November 15, 2026
- Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring. · retained source version 1:2026-01-27:current:3739d9c312cc5e16204ad753285f213b0641ea1f926f888637b3c889982d10ba ↗Source checked November 15, 2026
- Unique features of human cathelicidin LL-37. · retained source version 1:2022-12-07:current:09ff42a4ce253001d7e4392dc5ebe91acabd67870c2a8fb648185051b13ad4ae ↗Source checked November 15, 2026
- Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptor. · retained source version 1:2025-07-28:current:71806795cb0bd2d7a0dc524a202ee63b8954dcc47b6e36687340a546548037ce ↗Source checked November 15, 2026
- Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study. · retained source version 1:2024-10-15:current:3edc7665ee389ebe5aad49d0db387b0bc83b990db439ee47dc9305b9bece1c08 ↗Source checked November 15, 2026
- Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? · retained source version 1:2019-05-13:current:d013be82a3ecf85bab66e3dff68cde0a89677e0f42b0864a8d0c087537ca7ae9 ↗Source checked November 15, 2026
- Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman. · retained source version 1:2021-10-21:current:bbbdf023df70645d9cff51987bac1e534833a45d5d99dd25da12f366aff252de ↗Source checked November 15, 2026
- Use of Daptomycin to Manage Severe MRSA Infections in Humans. · retained source version 1:2025-06-27:current:c7c3acf182f9cf0e3ad1fe8e54aecebd6151afa8b88c9b3e6ecfd9d123885278 ↗Source checked November 15, 2026
- Use of goserelin in the treatment of breast cancer. · retained source version 1:2013-11-21:current:d930d72ce2ce0a6e445d0eea8b5f53992bafb197ab988a777b1689164302fb4c ↗Source checked November 15, 2026
- Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy. · retained source version 1:2026-01-27:current:4946f6ff1633c8d44b646b048a5250ab5f91b20ac1376ac7842e107ef4580b9b ↗Source checked November 15, 2026
- Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass. · retained source version 1:2018-12-02:current:12f6596be01be8da09913e110cfac6686934f1554ef25bff03bee2a74a281833 ↗Source checked November 15, 2026
- Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review. · retained source version 1:2018-12-01:current:b34bb820cf24599181ea17e2eed3e60171e2afc0e9975bb6999f46239441a773 ↗Source checked November 15, 2026
- Validated High Performance Liquid Chromatographic Method for Stability Study of Eptifibatide. · retained source version 1:2019-09-02:current:8fcdaecde2b486d4ef594139a23cc0546c324efaf7bba43eb1fb616021f3168e ↗Source checked November 15, 2026
- Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency. · retained source version 1:2008-01-23:current:969f043bddff6a606f88abba2a7ccb5802e664ce43155f0616fc8669b957163e ↗Source checked November 15, 2026
- Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA). · retained source version 1:2025-11-17:current:4e33113f71d6cdb51785bd50c35ca8c6305d5520c0602002d7c831adf2d96c19 ↗Source checked November 15, 2026
- Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis. · retained source version 1:2021-12-21:current:a527b5764cf4c4d8c4b9beead91ab4e029e8a6cd73f6cbf021cc22b3ecba6571 ↗Source checked November 15, 2026
- Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis. · retained source version 1:2022-07-16:current:a856374139be33a35634469cdf1ea8c09ceaedcbbeb03edbf4e0194ecead86d5 ↗Source checked November 15, 2026
- Vasopressin 1a Receptor Antagonists for Pathological Aggression in Neurodegenerative and Other CNS Diseases. · retained source version 1:2026-08-13:current:67201f09be5313f9955d654a98541d3933841b959d2b4716c38139531d586bd0 ↗Source checked November 15, 2026
- Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise? · retained source version 1:2025-08-02:current:bfc14555254fe714213038bce3dbb983d93c67a31d46dafc4db7e067aff3b1d1 ↗Source checked November 15, 2026
- Vasopressin and steroids in addition to adrenaline in cardiac arrest (VAST-A) - A randomised pilot study. · retained source version 1:2026-04-30:current:03c4ba3bcb9c466521b102b5a34c9bef42d8b7d28687c6e0b11cb81fd25629af ↗Source checked November 15, 2026
- Vasopressin in traumatic hemorrhagic shock. · retained source version 1:2025-05-23:current:bea9360e7cdd18785dac851542a6b0986f84f88d06070636d48dad08c78f64f8 ↗Source checked November 15, 2026
- Vasopressin Versus Norepinephrine As First-Line Vasopressor Therapy for Vasoplegic Shock Following Cardiac Surgery: A Systematic Review. · retained source version 1:2026-08-13:current:4ec85b9d123fc7f617f7d983ba9c11678f600524ac8d2e952f46f60eecb1c0d8 ↗Source checked November 15, 2026
- What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant Staphylococcus aureus bacteraemia? A review. · retained source version 1:2021-12-23:current:2ec164e698bb8ef9857949549df7d2864e53627737776ad12c9fdae92c66f3e9 ↗Source checked November 15, 2026
- Zilucoplan (Zilbrysq) for myasthenia gravis. · retained source version 1:2024-04-08:current:14f7d8abd3b8c959e085e6cf3cc7feedf090ebc1f4299e7bc7b3eb832b617913 ↗Source checked November 15, 2026
- Zilucoplan as a fast-acting treatment for severe myasthenic exacerbation: A case series. · retained source version 1:2025-09-11:current:af3502c01a3215506d0bf26fe211461f5fc9e3d0cb7a0b322bfb4b6696291ac5 ↗Source checked November 15, 2026
- Zilucoplan as a rescue therapy in myasthenic crisis: a case description and summary of early report experiences. · retained source version 1:2026-10-28:current:2703b5407a33f2cb12c882f6b0683a265034baa4e7a28876b0e23ad1ac2a5223 ↗Source checked November 15, 2026
- αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells. · retained source version 1:2019-09-11:current:b88a58c169c9673ca0afa40c88c3b34248d1c3c1fc9e1e5a4f43288e19111745 ↗Source checked November 15, 2026
- A Multimodal Intervention Including Tirzepatide in Women with Lipedema and Excess Body Weight: A Pilot Case Series. · retained source version 1:2026-11-14:current:4d986e252d9ee1b330372848e3932865994813c79b68fe53735f3fad8dbc316c ↗Source checked November 14, 2026
- A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study. · retained source version 1:2026-11-13:current:3af6ea5f41c67c1e8d84ce6ffc9fd67581d1248af12a09609544317f300deb90 ↗Source checked November 14, 2026
- A redox route from cysteine to glucagon secretion. · retained source version 1:2026-11-11:current:c15323873e2d30a5a83e20c08742ca1f8bd11e0c7ffba18695b82c308879c560 ↗Source checked November 14, 2026
- Adrenal hormones in the maintenance of glucose homeostasis during prolonged fasting in male glucagon-deficient mice. · retained source version 1:2026-10-19:current:319e7e7ad19b883d0e98c501d4705e41bac87e415be3a2b7d1bb563e4867a0d7 ↗Source checked November 14, 2026
- Anaphylaxis to tirzepatide confirmed by positive skin prick testing. · retained source version 1:2026-10-09:current:b1d1ded8f67b9a192fdab018a39529c5e6221998ccc11929f45fb98305462560 ↗Source checked November 14, 2026
- Boerhaave Syndrome: Case Report on a Rare Complication of Semaglutide Use. · retained source version 1:2026-11-09:current:e371c8858168c324d6ca91b0c8703870fe0ca2b746750f72a69d8ca935be8cfc ↗Source checked November 14, 2026
- Bone-targeting engineered exosomes delivering teriparatide mRNA for the treatment of osteoporosis. · retained source version 1:2026-10-26:current:e8fb7de8524ee580723d4afca1e66455352723c7ad70c600a121b3dc9c88098a ↗Source checked November 14, 2026
- BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence. · retained source version 1:2026-09-29:current:a4daaa0443633ba53f9cb780662ecf45765bd6d1612b706aec0350f8cceac79e ↗Source checked November 14, 2026
- Cascaded deep learning for synthesis of 18F-FDG PET from 18F-octreotide: model parameter optimization and performance evaluation. · retained source version 1:2026-11-01:current:edeace7d544770cb07d25ff048f160cd7bf1d03e0924fbd56b603fccb427b2c0 ↗Source checked November 14, 2026
- Case Report: Neurosurgery, octreotide, cabergoline, radiotherapy, pasireotide and pegvisomant - a multimodal strategy for adolescent acrogigantism. · retained source version 1:2026-11-05:current:b12052a1fd1b399aa5de50fa14c0ca9ca06df1b14bfe5b75b567c68209390011 ↗Source checked November 14, 2026
- Conservative Treatment with Adjunctive Use of Teriparatide for Periprosthetic Humeral Fractures after Reverse Total Shoulder Arthroplasty: A Report of 6 Cases. · retained source version 1:2026-10-19:current:3dcc70ea97e63ef8390b0530e741b599ac6641514ec63c43ed4a6079f5584e5e ↗Source checked November 14, 2026
- Dendritic Mesoporous Silica-Modified Decellularized Bone Matrix Scaffold for Sustained Teriparatide Delivery in Bone Defect Repair: Characterization, Drug Release, and In Vitro Biological Performance. · retained source version 1:2026-09-29:current:5085ca3ad2d25909fe48aa3429696353497a95d308cbd37ab6817876d09c1bd6 ↗Source checked November 14, 2026
- Describing pharmacists' perspectives on current practices and barriers to outpatient glucagon use in people with diabetes. · retained source version 1:2026-10-01:current:f23222dc8233f27156510da3ca2fd156e53dba09669ea6ffc1a76f46c531409f ↗Source checked November 14, 2026
- Detection and Excretion Profiling of Semaglutide Use in Human Urine by UHPLC-HRMS for Anti-Doping Purpose. · retained source version 1:2026-10-02:current:606a981bdd7b2280adb5bc7085a3d7836adc8437d9f9de2b84165e9de1f5b30b ↗Source checked November 14, 2026
- Detection of CJC-1295 in Equine Plasma by ELISA. · retained source version 1:2026-10-15:current:3f12e000e3bd53b74f615b26de7150626f7947d96c053f78c7029698bf98776e ↗Source checked November 14, 2026
- Development of Long-Acting Teriparatide Analogues through Iterative Peptide Scanning and Site-Specific Modification by Serine/Threonine Ligation. · retained source version 1:2026-11-12:current:1b770adb1b35c6590e8c685921d3db6477c8ec1604d3cf7a80fb65836548a67f ↗Source checked November 14, 2026
- Early Body-Composition Trajectory During Tirzepatide Treatment for Obesity: A Real-World Bioimpedance Cohort Study. · retained source version 1:2026-11-14:current:7c529f2353488fb01ecde9809df1c70f7712b0637622d89f74a7c92a5f3beca0 ↗Source checked November 14, 2026
- Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia. · retained source version 1:2026-10-03:current:5b19e3648d97a9565f00341b1a035ae4c0dbb385c9ed775f692a5f2f2c62ab1f ↗Source checked November 14, 2026
- Early nutrition impacts later setmelanotide treatment of obesity in mice. · retained source version 1:2026-11-09:current:f97fa276f19fb7a103865436a006fec301027b69240d08159756806c6cc37c76 ↗Source checked November 14, 2026
- Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide's Anti-Arrhythmic Mechanism. · retained source version 1:2026-10-18:current:48555e396c177bead4fa78434a134e69b539884ee99dc21cb75f1752d16a406d ↗Source checked November 14, 2026
- Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence. · retained source version 1:2026-10-20:current:67d4c676a3fb5a67b264ca4bcb9f5e27dc6164e90346f83c535a78204c319c25 ↗Source checked November 14, 2026
- Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes. · retained source version 1:2026-10-06:current:e3c5c018481af267418739a4db11b00c8f64ecf0eccfc818592ae3cda76321cd ↗Source checked November 14, 2026
- Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications. · retained source version 1:2026-10-07:current:e496a7300ef85c7c2739967ea6ff56cd11513174fe68922e7d5782412964297f ↗Source checked November 14, 2026
- GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. · retained source version 1:2026-09-29:current:c5ec6a2f80df5da00348eca37f3c0d45261ebfa1fc04c1cf1de97213c5207523 ↗Source checked November 14, 2026
- GLP-1s and criminality: US trial will test whether semaglutide can fight crime. · retained source version 1:2026-10-20:current:266c1549c0a234df360d541503fa08dc18f63761c3cba46053ebbea0b9e80a97 ↗Source checked November 14, 2026
- Glucagon receptor agonist aggravates a murine model of Balkan nephropathy. · retained source version 1:2026-11-02:current:bad4d131c0b2fa10fb529d76b37f8f2a518423f3116fd257028eaa8f14de67b9 ↗Source checked November 14, 2026
- Interpreting Survodutide Renoprotection in a Hyperfiltration Model. · retained source version 1:2026-10-19:current:6d399938aaae9700752344d0ffc642c4bc73512db21eb3da1f670ac9651fb7d1 ↗Source checked November 14, 2026
- Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study. · retained source version 1:2026-09-30:current:720ad5b64a72166abf418e1673c8df3f76a1b3c37ba488c6d1d3d1ff1acda781 ↗Source checked November 14, 2026
- Leuprolide acetate, a GnRH agonist, preserves cerebellar integrity and motor coordination in a rat model of hepatic encephalopathy. · retained source version 1:2026-11-06:current:a9c10c81369ac410792fe219332cb79d14d9242b1d63a5dc2ae63f157cfb2a38 ↗Source checked November 14, 2026
- Liraglutide in Adults With Obesity: A Multicentre, Single-Arm, Post-Marketing Surveillance Study in Taiwan. · retained source version 1:2026-09-23:current:91f134f20722b2335e384dcb605ca99455ecdfa0ae54e33544a0b25b0bacb04d ↗Source checked November 14, 2026
- MAFB is essential for the maintenance of adult human α-cell identity and glucagon secretion. · retained source version 1:2026-10-08:current:38de16aeaeef3d96960f5c4e9abb9c28c8fd79de0cfe30006ad1c1bb1087a2c1 ↗Source checked November 14, 2026
- Mechanistic Basis of Octreotide Therapy in Neonatal Postoperative Chylothorax: A Translational Case Report. · retained source version 1:2026-10-28:current:3d358a18b56fbda1e352269beb792cb7d919131777b5f3e2f0a016b593b86ca4 ↗Source checked November 14, 2026
- Medication-related osteonecrosis of the external auditory canal and treatment with teriparatide. · retained source version 1:2026-09-18:current:94b6e760f99fe040ee5247cc91a76d58061f432e10be3cfa799dbf904439ef3f ↗Source checked November 14, 2026
- Octreotide-modified pH-responsive nanocomposites for ultrasound imaging-guided chemo-photothermal therapy of prostate cancer. · retained source version 1:2026-11-12:current:f9047d3489ae478071d004b4a6984f250b4d21054c20eba349c4b1afce901f4f ↗Source checked November 14, 2026
- Original rDNA Semaglutide Versus Synthetic Copies: Differences and Clinical Implications. · retained source version 1:2026-09-23:current:d3abbd23b1451c91fa2a5c6e76638e2cdd8d21b270e59485b32c72d0fe77d85f ↗Source checked November 14, 2026
- Oxalate Nephropathy in a patient with Neuroendocrine tumor receiving Long-acting Octreotide. · retained source version 1:2026-10-29:current:52acb08cdc3acc59c4cff354e1013e8607580f8bab0ff74e1362f5aef91549b6 ↗Source checked November 14, 2026
- Perioperative teriparatide use in osteopenic and osteoporotic patients undergoing multi- and long-segment posterior spinal fusion. · retained source version 1:2026-11-09:current:02b83d92faa911e377451ffbc895a2416f0c1f9a7fc979a2911ff9ed669e1b09 ↗Source checked November 14, 2026
- PET Imaging of Dual GLP-1R and GIPR Targeting with [18F]AlF-NOTA-Asp2-Tirzepatide. · retained source version 1:2026-11-02:current:dae7d55a16de351952089d0bad7230d02331aa8364ed9305e9054c3470affe3e ↗Source checked November 14, 2026
- Petrelintide and the evolving role of amylin agonism in obesity. · retained source version 1:2026-10-13:current:4197fa94ebcfd9d2f4f0875be362a9535f6d7ba099aad77c52e42f0398db1502 ↗Source checked November 14, 2026
- Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy. · retained source version 1:2026-09-21:current:5b1b4aab539131c0db64d6d2f18a0e26c44a3a3e5d995e1a898fd8f8c53b4bdd ↗Source checked November 14, 2026
- Recommendations for the use of semaglutide for the management of obesity in children and young people in England: expert consensus statements using a Delphi-like process. · retained source version 1:2026-11-03:current:9d7c542008957bad0fd8e8d33ece67d01b1fc632e048d408f749efb8ae9188b7 ↗Source checked November 14, 2026
- Retatrutide in adults with obesity and type 2 diabetes: what have we learned from TRIUMPH-2? · retained source version 1:2026-10-08:current:8017a2678e673d781b61acbeb25e29103a8a310c939aa9b13c682a57a025e7e4 ↗Source checked November 14, 2026
- Role of Liraglutide in weight management and reproductive health in women with obesity and PCOS- A critical review of the evidence. · retained source version 1:2026-09-12:current:254709a8d37878eaaaaac4170c327ef18852d08634032232516965f9b259a11e ↗Source checked November 14, 2026
- Semaglutide and alcohol use disorder: An evidence gap India must fill. · retained source version 1:2026-11-12:current:613409fd6beb4e2b0b882a4eb9203b328d54cd8923d3536f96ae8f4a8e044624 ↗Source checked November 14, 2026
- Semaglutide for MASH in Japanese patients: findings consistent with the overall ESSENCE population. · retained source version 1:2026-10-28:current:9e86c5ca2454fdaf310b44749beb054f5d2f03ac36bb39428a9bc6c8dde5d198 ↗Source checked November 14, 2026
- Semaglutide in Bipolar Disorder: A Differential Finding Needs a Differential Mechanism. · retained source version 1:2026-09-18:current:d714d069297d875260265f2d1afebd9bd494aca9c09708908ae5d14309bc127c ↗Source checked November 14, 2026
- Semaglutide in Heart Failure with Preserved Ejection Fraction and Obesity: The Gap Between Discussion and Use. · retained source version 1:2026-10-12:current:6f44c0e7d11a72e03ca7083d9e6e483164f3cb1d74d18a5a702c698ba2882c2b ↗Source checked November 14, 2026
- Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. · retained source version 1:2026-10-14:current:2da91ab04040d05c65c731d60b72a01c50ed4ebc2c705a270234f2d48e0d2f59 ↗Source checked November 14, 2026
- Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. · retained source version 1:2026-10-14:current:ddad325ad797786127561129ec54671c2a1a37e88732c287549290cde3a1f120 ↗Source checked November 14, 2026
- Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply. · retained source version 1:2026-10-14:current:07d74af141239acc6794a6cd6c3047019f826c36222e866305f91529fefbc7ab ↗Source checked November 14, 2026
- Stabilization of Glucagon by Trehalose Diblock Copolymer Vesicles for Hypoglycemic Counterregulation. · retained source version 1:2026-10-23:current:80fdc67e913bcb8850efa73c4cc35fba5d027a1949904145513fff182049e71b ↗Source checked November 14, 2026
- Temporal dynamics and prognostic value of serum calcitonin during tirzepatide therapy in adults with obesity. · retained source version 1:2026-11-10:current:0c03717a441aca8831fe264814cefc20149fa9200186608a3f8e3522eddb640a ↗Source checked November 14, 2026
- Tirzepatide among patients with psoriasis and obesity. · retained source version 1:2026-09-29:current:85a64632acd376f9579c7bb206f9f3131c21d34b1e028cbc408e17faa9b2454e ↗Source checked November 14, 2026
- Tirzepatide preserves hematopoietic stem and progenitor cycling while remodeling inflammatory monocytes in obese mice. · retained source version 1:2026-10-30:current:2a85124908d8c34c2bdbd67d6528170a10ffbc27977faf173f5bcead28d02741 ↗Source checked November 14, 2026
- Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain. · retained source version 1:2026-11-03:current:1bf66f841ad0b67ede83bbe8cbab027e6d4f32763bc22bdb21f73a8786a3bc13 ↗Source checked November 14, 2026
- US Healthcare Professionals' Management of MASH and Self-Reported Knowledge of GLP-1, GIP, and Glucagon Receptor Agonists. · retained source version 1:2026-11-12:current:0ff0af95e81b4c258b98c51a7895524e7a4ca6ce50e2c993f1df871c660b21f9 ↗Source checked November 14, 2026
- Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia. · retained source version 1:2026-11-06:current:f33202b44673d372e02e01e4cd3e29de64c17b3f570a2f466d8bb0323fc6d4fe ↗Source checked November 14, 2026
- Wegovy: GPs are told not to prescribe GLP semaglutide for heart health without funding guarantee. · retained source version 1:2026-09-10:current:fe91a46487749b48b0012c0b190732c2fae71a40426ee2c34450ab6d74c20ba0 ↗Source checked November 14, 2026
- "I Believe in Santa Claus" and Ozempic: A Foucauldian Discourse Analysis of Holiday Health Advertising. · retained source version 1:2026-09-09:current:cc6ee533feac82aee9e1e6e31730f4730c7345c174dd2d964bc2ec5a69921982 ↗Source checked September 9, 2026
- [Pharmacological treatment of gastroenteropancreatic apudomas with an analog of somatostatin, SMS 201-995 (octreotide)]. · retained source version 1:2013-11-21:current:9a8729f4ee3795bba86fb5c8f156b79ed924f6fc4e811457175c63f3d04a2cef ↗Source checked September 9, 2026
- A cDNA construct allowing the expression of rat hepatic glucagon receptors. · retained source version 1:2006-11-15:current:d89686dcbf0b967f5b906a0a897ec7c6d5bf041102925ec5e769403eac80f4c1 ↗Source checked September 9, 2026
- A long-acting octreotide analog formed by conjugation with a peptide linker modified with two fatty acids. · retained source version 1:2026-09-09:current:36f27a718dd53f76368cf564f08cae7a41857334e4c3d6f76a1390a1b9d98c68 ↗Source checked September 9, 2026
- A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. · retained source version 1:2026-09-09:current:3296b303c9139f7f941f253495615824e23db2faf2f9883190a3e6c174b16ec4 ↗Source checked September 9, 2026
- A second glucagon in the pancreatic islets of the daddy sculpin Cottus scorpius. · retained source version 1:2006-11-15:current:8c279520c763ef677de7747a8c2ffcd646270a6818bde4c8e9883bc7be0cf00c ↗Source checked September 9, 2026
- Are We Asking About Tirzepatide? Emerging Oral Health Implications for Oral Medicine Practice. · retained source version 1:2026-09-04:current:efd36a686ea870ea3bcc1e2b23b3ec2c36225da13b15b4f30e2e699be45b7c82 ↗Source checked September 9, 2026
- Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats. · retained source version 1:2020-12-30:current:0195fef89f1e77cfb42f98674d455d261cfe263ef05e8bb1c947b6635171052d ↗Source checked September 9, 2026
- Development of Chondroitin Sulfate ‑ Stabilized PLGA Microspheres of Exenatide via Polarity Gradient Extraction. · retained source version 1:2026-09-08:current:8c8d68644f0e4309bffafab6f38dd66c4112e84053f6d3c64f74fef6e5ae464e ↗Source checked September 9, 2026
- Early callus formation in human hip fracture treated with internal fixation and teriparatide. · retained source version 1:2013-11-21:current:eaeb5f94017f68f85f64acfe6eb90866273c9309441e37918697abacc0730ac4 ↗Source checked September 9, 2026
- Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome. · retained source version 1:2023-02-26:current:d432cc74866dc520e09ffc1f10685e17cc6399b5a5fe3aab3284c91a636d8662 ↗Source checked September 9, 2026
- Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. · retained source version 1:2013-11-21:current:58a3029d944477bff460e7f6c408e3ad4b7f55f87550013fba128f0f958b808d ↗Source checked September 9, 2026
- Monitoring Liraglutide Oligomeric Interconversion and Fibril Dissociation through High-Pressure NMR Spectroscopy. · retained source version 1:2026-09-08:current:e64e298b159c447ce0472b3b62186d2af017cd709de6aa78faf5179bf245268b ↗Source checked September 9, 2026
- Multiple forms of glucagon and somatostatin isolated from the intestine of the southern-hemisphere lamprey Geotria australis. · retained source version 1:2006-11-15:current:d35a6d2bd04ace00c7a5dda86d92beea5858deea543c2c9985e7a88d1b2eee64 ↗Source checked September 9, 2026
- Off-label semaglutide: A call for monitoring protocols in non-obese populations. · retained source version 1:2026-09-07:current:0980524a08e7b8526a46aafdaae02e1a06e5a60fb341abe11b3cf13e86254086 ↗Source checked September 9, 2026
- Ozempic and thin line between therapy and dependence. · retained source version 1:2026-09-07:current:1422a919825417fee86e0dcaad8d4b63eef3b874e4e3044aad64887ff8054667 ↗Source checked September 9, 2026
- Primary structures of glucagon and glucagon-like peptide isolated from the intestine of the parasitic phase lamprey Petromyzon marinus. · retained source version 1:2006-11-15:current:1f821d228c092de13562894786b16da490cdc38c523958987fd0660ec6a78160 ↗Source checked September 9, 2026
- Region- and age-specific differences in proglucagon gene expression in the central nervous system of wild-type and glucagon-simian virus-40 T-antigen transgenic mice. · retained source version 1:2006-11-15:current:c00fb6865b3b05f10480b7ab98398bb18de5a5aec84b484804fb70c37fd92561 ↗Source checked September 9, 2026
- Targeting glucagon signaling in metabolic disorders, functional insights from zebrafish receptor knockouts. · retained source version 1:2026-09-09:current:a276654a75a4c74e7165bc986904110e9922549f97dbcf6749442817263b8b06 ↗Source checked September 9, 2026
- Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress. · retained source version 1:2026-09-08:current:9c22a430cf58fa20690de0975c3a3f218033d7441e568837258b455c1c24d378 ↗Source checked September 9, 2026
- The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours. · retained source version 1:2018-02-16:current:d4200e746a01c9a70fd14d7e9637543607bf5159be679c4e6c89ac3de5cc165a ↗Source checked September 9, 2026
- Ultrastructural pattern of glucagon producing-cells in the gastric mucosa of the developing opossum Didelphis albiventris (Marsupialia). · retained source version 1:2006-11-15:current:a6a9c3f6fc8caa09baef02856410b8d8a1a75c78c6c0e6cc1b6f1b0c0107eea4 ↗Source checked September 9, 2026
- [A-cell-hyperplasia of islets of Langerhans on rabbits after immunisation with glucagon (author's transl)]. · retained source version 1:2006-11-15:current:c11dc08ac825a9cc6453cd6d13ca52a8f4a3dc8f5d63243a671b23254deec1c4 ↗Source checked August 16, 2026
- [Glucagon-producing carcinoid of the rectum--report of a case]. · retained source version 1:2006-11-15:current:3bf49415818745718bb4785bbc75c6ac80a21215110ff98dff139950f302f049 ↗Source checked August 16, 2026
- [McArdle's disease: therapeutic use of depot-glucagon]. · retained source version 1:2006-11-15:current:cd6185310669c2f5c1856ddc007aeadcc6b924896934ed3a5d9215172ec78a82 ↗Source checked August 16, 2026
- Behavior of amphipathic helices on analysis via matrix methods, with application to glucagon, secretin, and vasoactive intestinal peptide. · retained source version 1:2006-11-15:current:91c0f8b58d89b17e771de734f1b849d6497ecc7d7f08fc8a67a18fb00bdb954f ↗Source checked August 16, 2026
- Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia. · retained source version 1:2018-12-02:current:1a73acad25f28ec52d08973e0f7635c3e8e1033708ee4c8269d8e82d9b4ec13a ↗Source checked August 16, 2026
- Clinical observations of exenatide treatment. · retained source version 1:2018-12-01:current:dbd81a0f3835988a3e0ec34197012f3a9144a6c3b377e5ff9dc9793b4150e34b ↗Source checked August 16, 2026
- Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists. · retained source version 1:2026-06-25:current:02c52228e57a7c394f35c1e8133427046e54d5c50ffcc62fdf2b762a4c05e0ff ↗Source checked August 16, 2026
- Geographic Disparities in Glucagon Prescriptions Across North Carolina. · retained source version 1:2026-08-14:current:884a4ac7d626f64a1ccf90d4198e688ffaf85d38e1bdec6cad79a94a03afdd26 ↗Source checked August 16, 2026
- Glucagon-like immunoreactants in extracts of the rat hypothalamus. · retained source version 1:2006-11-15:current:1f72b2cd7cfbeef82157e8118b2d6df0a8c57af3ea6e0eead612c78085f1269b ↗Source checked August 16, 2026
- Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic administration. · retained source version 1:2026-06-26:current:dd6596df5f2e809ce6be2e8fc83bc0ab217637780b0ae6c5218a376677e7c356 ↗Source checked August 16, 2026
- Immunoreactive glucagon in neurons of various parts of the human brain. Demonstration by immunofluorescence technique. · retained source version 1:2006-11-15:current:73cd203493812042315bb5a206210223838003e2645115042ea12eeb5a32f9db ↗Source checked August 16, 2026
- Linaclotide (Linzess) for functional constipation. · retained source version 1:2023-09-05:current:57254ae959e95992531467de5b8f45be7376f6ec412ff17a24be8cfa8a85230b ↗Source checked August 16, 2026
- Liraglutide in Children and Adolescents with Type 2 Diabetes. · retained source version 1:2026-05-18:current:8b5c4909931ec813fd57aac5d5b380f79883e8998bd183435e267948e20bebd2 ↗Source checked August 16, 2026
- Normal vibrations of proteins: glucagon. · retained source version 1:2006-11-15:current:12e1c159b0a39b350204064b150708659bc945772fab468bffc8399ad03bfe5d ↗Source checked August 16, 2026
- Octreotide and Octreotide-derived delivery systems. · retained source version 1:2026-06-28:current:f3c11f50c77d576559aee49765534e6d1d0c87b85ba035db17d09abc85b5778b ↗Source checked August 16, 2026
- Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States. · retained source version 1:2026-06-26:current:bbb71d7f68d0069e0fc86a1ce914b34739ea949e7302b1548d9f6b19bfc5987e ↗Source checked August 16, 2026
- Secondary alopecia due to semaglutide. · retained source version 1:2026-06-27:current:fe397cdcc044c416140262cd61d154e87c2beca956d333a1be982c1e4f1b397a ↗Source checked August 16, 2026
- Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats. · retained source version 1:2024-08-18:current:405e2fc8184e8725d89c54b212ef2055f842c9e2a63ec6575da863d792b790f6 ↗Source checked August 16, 2026
- Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS. · retained source version 1:2022-08-09:current:48182ebbcc7015ebe535887f57c06a9ac6b6b1524a644f0869ae918a03bf634f ↗Source checked August 16, 2026
- Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS). · retained source version 1:2026-05-18:current:c0063f129f2bb27b4573de16faffd3d7fc1c562d4b5b15f9b8df8210e5a00fa0 ↗Source checked August 16, 2026
- The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids. · retained source version 1:2013-11-21:current:c79e875f69217382cdaebf27c1565b9a04d9a2ea925a9c6b3c1034fa2dc99777 ↗Source checked August 16, 2026
- Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD. · retained source version 1:2026-04-27:current:30178300daa1e9698346f08b937a549c6c2bc040359d214907b0595b9ffdc852 ↗Source checked August 16, 2026
- Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide). · retained source version 1:2013-11-21:current:2290e5574383619557754336864f60d972e0c36c633119bf5829a895bf4edf71 ↗Source checked August 16, 2026
- Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter. · retained source version 1:2026-08-15:current:d7b09e1ada6ca8247017322a8c94cb5c1f90a19b5a84f84fd35996d27ac02abb ↗Source checked August 16, 2026
- [Basal insulin and liraglutide combined in a pen]. · retained source version 1:2015-11-19:current:a33bdf9c768553aae6047203a35f623f0b64e0ac38b92908eba07bd7c63ecaa5 ↗Source checked August 14, 2026
- [Clinical applications of octreotide in gastro-entero-pancreatic (GEP) tumors]. · retained source version 1:2013-11-21:current:8c5db0adeaef4c177e5cd52383aa8aecb12e0d12669c3dc6b751f17a1667c057 ↗Source checked August 14, 2026
- [Concentration of gastrin in serum, gastric and duodenal tissues and gastric argentaffin cells following administration of pancreozymin and glucagon]. · retained source version 1:2006-11-15:current:fbcabb4ed962df9f945370b15fa55cfab263cf3542a5975a41bb6e9245a3f24d ↗Source checked August 14, 2026
- [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands]. · retained source version 1:2006-11-15:current:fa0d071b0c5796c38c27523c4350281ec2c9d2ad52f7b4e803ecd1fbcef7f471 ↗Source checked August 14, 2026
- [Exenatide--an incretin mimetic for treatment of diabetes mellitus type 2]. · retained source version 1:2018-12-01:current:0e886ad4e133c39052a53c44640f6619f2b765ac7da98bf4fb21ed36b60a9e2a ↗Source checked August 14, 2026
- [Glucagon and impacted food in the esophagus]. · retained source version 1:2006-11-15:current:be0ccb86b080a3f66ce40f6271fca7a178e05ced64406e7eaa1f69ea2cae6d8b ↗Source checked August 14, 2026
- [Glucagon and water overload as medical therapy for the spontaneous expulsion of ureteral calculi]. · retained source version 1:2006-11-15:current:2c39fab6d9aa238cab8d953d7c9e608280cca9054951c09090ef00bb042c8707 ↗Source checked August 14, 2026
- [Glucagon-related polypeptides in health and disease]. · retained source version 1:2006-11-15:current:9f0b04787eb40d69458cef29400c412e806ed35098413785bdf4aa2878fab0a2 ↗Source checked August 14, 2026
- [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide]. · retained source version 1:2026-07-01:current:eac1b13e51605cf1b65fe618b1e94da173ee4375c6ede68cfa20eb907a9f7384 ↗Source checked August 14, 2026
- [Immunogenic properties of glucagon: the interaction of glucagon from the hen with specific antisera to glucagon from mammals]. · retained source version 1:2006-11-15:current:197777c8ae624af4064c9f2b703e39cb2dbbc177aa773df2a13d286d359d586c ↗Source checked August 14, 2026
- [Immunoreactive insulin and glucagon levels in chronic alcoholism patients]. · retained source version 1:2006-11-15:current:aa8ba87b9913f374ade49682dde39fd915558d7e5256d9533f5ddb4ec9078998 ↗Source checked August 14, 2026
- [Intraoperative spasmolysis with glucagon in an irreducible invagination]. · retained source version 1:2006-11-15:current:c0153134dd7eed983ed4b0bd182f1eee7ba919575610767d02b2dca1b9141418 ↗Source checked August 14, 2026
- [Modification of the motility of stomach, intestine and gallbladder by octreotide]. · retained source version 1:2013-11-21:current:7753958a8345556842940750a519a47ea745d61abd05ee7d0423cfda654be551 ↗Source checked August 14, 2026
- [Nasal administration of glucagon in the treatment of neonatal hypoglycemia]. · retained source version 1:2006-11-15:current:1b2ec4cfca16e74d86c2240131a1db53e990c1ea579c9b633fa73bd380645035 ↗Source checked August 14, 2026
- [Overcoming uterine tube spasm during hysterosalpingography with glucagon]. · retained source version 1:2006-11-15:current:8af7400db06434426442f416810fd44335dc08a3a0ff449f41c638cd885a8269 ↗Source checked August 14, 2026
- [Possible intervention of glucagon in the genesis of various primary hyperlipemias]. · retained source version 1:2006-11-15:current:4be533a8030946c2bfb3ffd592948bfd2b81bd1c559ffe7e4e2ff110c6af7c22 ↗Source checked August 14, 2026
- [Procedure-reliability studies on radioimmunologic pancreatic glucagon determination]. · retained source version 1:2006-11-15:current:14c1a6e14af9bc537fed9c66e7fc8f1d316075309e95ab85b58d77c8f6fb0ef4 ↗Source checked August 14, 2026
- [The glucagon syndrome]. · retained source version 1:2006-11-15:current:fd1198ba2e11345e6e213970677ba814ae41489e0b0b289610f875b0965eaa69 ↗Source checked August 14, 2026
- [Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog]. · retained source version 1:2016-12-09:current:c79dc4a68c382253ef4da8fcee618d6ad13bb2dabb894870643120d36a3f21e6 ↗Source checked August 14, 2026
- A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review. · retained source version 1:2026-08-13:current:fefe26906d6ad69924bc6c60f4405ffbd6270c9bd298323652a1c2a9a7d0e1d8 ↗Source checked August 14, 2026
- A Computational Glucoregulatory Model of Liver and Glucagon for the Evaluation of Therapeutics. · retained source version 1:2026-08-13:current:4acaa653434827f6782a097ee4b5a03c7865f9ecae52776ce7f057f389c4305b ↗Source checked August 14, 2026
- A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes. · retained source version 1:2026-08-13:current:fd804ff59be9f87afdd580e361a4a46c7a5568fb21223cdb9906f2f1a2ad78e4 ↗Source checked August 14, 2026
- Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors. · retained source version 1:2022-03-16:current:ecac09149a1d6a5bbbd4cd2fb1d67a17b9b153dee6a06438e74a15d7c0855045 ↗Source checked August 14, 2026
- Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance. · retained source version 1:2013-11-21:current:9b393dcb116d314acf0da804b903ea993231287b24212ef9e300de0f500f73e4 ↗Source checked August 14, 2026
- Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy. · retained source version 1:2026-08-13:current:7f65e384716dd6476de3e6e48a96075d9c3488791d66d13569f92bbe8d841064 ↗Source checked August 14, 2026
- An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system. · retained source version 1:2020-07-03:current:248ecc4376ae3696bf6b0d752b8aea02f2f140a6f9127872ba389d515dd5b248 ↗Source checked August 14, 2026
- An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC). · retained source version 1:2026-06-28:current:4eaaed92a7ff722eb23cecc2a7e84be650082a609fedaff2562e7a9649939c70 ↗Source checked August 14, 2026
- Application of the OBIMAP (One-Bead Interchain Multipeptide Assembly Platform) to Long Peptide Synthesis: Liraglutide as a Case Study. · retained source version 1:2026-08-13:current:14ef80bd3f6dbd2d868a2eeda0f54537d048cd191df3a01f00239635ff664772 ↗Source checked August 14, 2026
- Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density. · retained source version 1:2026-06-29:current:34a9ec8bd4a40f52ec7370dba17e894b245c25404247f07518af2adf9ce77b3a ↗Source checked August 14, 2026
- Byetta (exenatide): what's your gut feeling? · retained source version 1:2018-12-01:current:b421818cdf956f3b023acfccd580373e0f31b06866c0ee3fded5e0bfa2af74a6 ↗Source checked August 14, 2026
- Can Ziconotide Be Used to Replace Opioids? Exploratory Clinical Experience in 5 Patients Treated in the Pain Unit. · retained source version 1:2025-09-25:current:dbd75782d87eb01550b003eaf45c11a038940533f0e6df82f7a6eb2359cb7ee2 ↗Source checked August 14, 2026
- Clinical Pharmacology of Glucagon. · retained source version 1:2026-07-07:current:1aab80fd2ce0ab3b84123f3710cbc67c11e89ffa107a5dc5d3af718bd8e25f58 ↗Source checked August 14, 2026
- Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma. · retained source version 1:2016-11-25:current:dc806b43134ceedf35151775ed56fb728d132411edb1e65904dccfdba61d2dff ↗Source checked August 14, 2026
- Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report. · retained source version 1:2026-08-13:current:0b1ac7241d1d46305d86af9e0e1d9807ea95012cc191d40d7d443846db416946 ↗Source checked August 14, 2026
- Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs. · retained source version 1:2026-08-13:current:7d54bf4840ac5fd2a4e97b9f12fb252d111c2c3b2586ecae8ca745977c37c4d4 ↗Source checked August 14, 2026
- Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosa. · retained source version 1:2006-11-15:current:2e9394c52fc6f5fd5b627252979986e3541f7c74a553b67632047af78e053f04 ↗Source checked August 14, 2026
- Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods. · retained source version 1:2024-10-11:current:e3d4f35f6429ee1827d74e270d82c7539c40fc0b12bcb9c49e51c9105d5deeb2 ↗Source checked August 14, 2026
- Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. · retained source version 1:2024-03-27:current:f752f49a1ea67ab8c7816615e9f540360698d9f1bf9fd7ea51eaee234991c325 ↗Source checked August 14, 2026
- Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. · retained source version 1:2006-11-15:current:99d4e8db5902dfcbeb3f02295fa8731be9afe00974e17ebac9ad09e573990401 ↗Source checked August 14, 2026
- Excessive circulating large molecular weight immunoreactive glucagon components in subjects with the idiopathic postprandial syndrome. · retained source version 1:2006-11-15:current:7b7e31707d3f4a6865991f1cba08ec21c3dea7625d60483ee21db7c09fd756ba ↗Source checked August 14, 2026
- Exenatide (Byetta) for type 2 diabetes. · retained source version 1:2018-12-01:current:6048229a271c7fd1e3b2b62dbf6eef74b4edc308001d96c8891ffea7d1b572b1 ↗Source checked August 14, 2026
- Facial nodules following filler injections after initiating compounded tirzepatide use. · retained source version 1:2026-08-13:current:f19c1f56cf97585736ca43a7c637b247f65c571a0f50e378324f44bb1caa47c5 ↗Source checked August 14, 2026
- Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel). · retained source version 1:2026-01-28:current:d803d8ef110c4653974c3a80952a3dd6ed0c8cc7285052ddf28a26605502340c ↗Source checked August 14, 2026
- Glomerulopressin activity in peripheral blood of newly diagnosed type I (insulin-dependent) diabetic patients and in normal subjects treated with glucagon. · retained source version 1:2006-11-15:current:8532ea9f62257697fe6b6b92182a50fcc1616c6cb0ebfc2317ecaffb7d52da6f ↗Source checked August 14, 2026
- Glucagon and VIP in the retina. · retained source version 1:2006-11-15:current:5bd2172d8bfc26985cf7828f56d27048157bc15a2a99aad2866f3980b2469f3f ↗Source checked August 14, 2026
- Glucagon antibodies alter Langerhans' islets. · retained source version 1:2006-11-15:current:fc1bb866caf8dbb186d8b9657c2157bbbd1b237ddcea2235d9df57c5aeb4af72 ↗Source checked August 14, 2026
- Glucagon secretion by pancreatic alpha-cells requires an intact tubulin-cytoskeleton-primary cilium axis. · retained source version 1:2026-08-13:current:e50c8e9a3c7d55911e341cf378b4529e3974c2e024fc19970df87b6047de57b5 ↗Source checked August 14, 2026
- Glucose-dependent dynamics of glucagon, cortisol and adrenocorticotropic hormone before and after gastric bypass. · retained source version 1:2026-08-13:current:5fc81e769fc519ee3745059c7acf9ceb30e570bb13be860440b42432a39ad01b ↗Source checked August 14, 2026
- Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status. · retained source version 1:2006-11-15:current:265f1cda1caee415c4df4080d24a28a6072fa649784530d4449324c661745a9d ↗Source checked August 14, 2026
- Identification of cells immunoreactive to antisera against porcine pancreatic glucagon in the gastro-intestinal tract of Xenopus laevis. · retained source version 1:2006-11-15:current:c1f8d2bf28e0439027454266c2ab6232b13aa0dbc893434e18b2c24a83d90d85 ↗Source checked August 14, 2026
- In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes. · retained source version 1:2021-10-21:current:4b129d2498b98594f36f6d94b9a2f7c0a48007c6832292a3cdeab66d79098870 ↗Source checked August 14, 2026
- Inflammation-mediated facial nodules to compounded tirzepatide. · retained source version 1:2026-08-14:current:2b079cc362b53630676caa02a1de041a7ab692c920125f3584f0ab06b4c3b041 ↗Source checked August 14, 2026
- Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes. · retained source version 1:2026-07-01:current:ed1a641aad8c51e378b331d5afcf9a55040a7ab98f9f9563d6032bd316a5298e ↗Source checked August 14, 2026
- Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research. · retained source version 1:2026-07-04:current:ae5da0e1b583f6eadab7ada1dda34ad78f0af0a77979bc5810d792499e718e5a ↗Source checked August 14, 2026
- Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective. · retained source version 1:2026-08-13:current:a2c2902cb293dd690ae2c89ab36c9a90ee26ef586cd330a254faaef297b8b48b ↗Source checked August 14, 2026
- LC determination of leuprolide component amino acids in injectable solution by phanquinone pre-column derivatization labelling procedure. · retained source version 1:2013-11-21:current:725bdcf8020a382696a66082142f6d1a93c862a99244cd53ffa509c9440aeb60 ↗Source checked August 14, 2026
- Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use". · retained source version 1:2026-08-13:current:0c195f7d324c89cff9eb353f7b605ec0a8fce5cef121d97d66b320fe11d22cd8 ↗Source checked August 14, 2026
- Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain? · retained source version 1:2013-11-21:current:4cd935df829f8bd1543e09360bee2bc753596571b55a92754a40fddafc9def16 ↗Source checked August 14, 2026
- Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations. · retained source version 1:2013-11-21:current:7317a09b57987c88642c99ee6106559e619fe7cb4297d1357526853a11180d81 ↗Source checked August 14, 2026
- Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism. · retained source version 1:2020-09-30:current:3ef14f6b75b75b0bd4ff2e081ee1f1bb4f7524e0444d5b99e1b23b74c1477b2f ↗Source checked August 14, 2026
- Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs. · retained source version 1:2026-05-20:current:a2078f3bf121c3a8f0f9a7485946820d1ed94d4de26087ed02cbd615709e5d40 ↗Source checked August 14, 2026
- Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. · retained source version 1:2006-11-15:current:27852c62229f5324c5dd71966d43136a267f121d757ce4820402e770f3fc249c ↗Source checked August 14, 2026
- Observations on glucagon treatment in pancreatitis. · retained source version 1:2006-11-15:current:fd16b59afc0ae9ee46fb4621e8e1da3a850426f7b573b82e03b07afc26a64681 ↗Source checked August 14, 2026
- Optimization of nursing strategies for semaglutide treatment in overweight type 2 diabetes based on gene polymorphism. · retained source version 1:2026-08-13:current:deff750a84c40ffc200de9a1cb7e76e157de7339abb99ad9cfc4dbf8809d984c ↗Source checked August 14, 2026
- Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects. · retained source version 1:2018-12-01:current:3417253d56362f19fca77770d56c0bdcaa8f68ff88f2a441b18032416d6a15fe ↗Source checked August 14, 2026
- Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States. · retained source version 1:2023-11-12:current:8489278e6d3874ece29b81e528b94fd4343163aa492f68683f6bf58c6d27e0de ↗Source checked August 14, 2026
- Pramlintide and the treatment of diabetes: a review of the data since its introduction. · retained source version 1:2022-03-21:current:ea360fab1177735145ca06a3b6935bf791ae9885ad83fee10ff0b0ab1b6556a2 ↗Source checked August 14, 2026
- Presence of immunoreactive glucagon in healthy and diseased human thyroid. Evidence of glucagon synthesis by this gland. · retained source version 1:2006-11-15:current:950f337d54ad81260a4bc5ada6e0058b485c6ac5dc2fa399e787071e3a93f87d ↗Source checked August 14, 2026
- Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet. · retained source version 1:2026-08-13:current:2e51dea7a67206253f86e951e4444f4bbb8d67075ec302936bcf4500ae72849d ↗Source checked August 14, 2026
- Real world tirzepatide treatment for fatty liver disease. · retained source version 1:2026-04-27:current:3b5833d9453153cb871b177a7dbed1e756c477207b8a301d62526b955ba80697 ↗Source checked August 14, 2026
- Real-World Indirect Treatment Comparison of Terlipressin vs Midodrine Plus Octreotide in Hepatorenal Syndrome-Acute Kidney Injury. · retained source version 1:2026-08-13:current:f7e7c2c507f6c4281c06579da10a83cf8aefd9e160f323eb207325cdcc10934d ↗Source checked August 14, 2026
- Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis. · retained source version 1:2026-08-13:current:2ea8ee5dcfc214f0ca25674823b33690a839e781e74430980e6137ba7721c140 ↗Source checked August 14, 2026
- Semaglutide in Schizophrenia-A Top Clinical Trial. · retained source version 1:2026-07-01:current:7625ed8753e36bc33c47804e38a7ef996f3e33eb3b40e41716fc264f4861ef72 ↗Source checked August 14, 2026
- Semaglutide use for hypothalamic obesity and type 2 diabetes mellitus after suprasellar germinoma treatment. · retained source version 1:2026-08-13:current:ccb89642cb0b45e2091f4c302f091c0ec37fe096014974289b8bc6418e48c159 ↗Source checked August 14, 2026
- Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis. · retained source version 1:2026-06-28:current:63aa11a5b51915c66ee4a30b06f00c853f7fbe5bd63e23838da4515605785351 ↗Source checked August 14, 2026
- Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review. · retained source version 1:2024-09-03:current:6df369da1631ef8536c1d3f0d9e3e928394e35a6ebdefa62298472812a1c5809 ↗Source checked August 14, 2026
- Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols. · retained source version 1:2026-08-13:current:11eeba203e0a0e4145e347e28669368d99491319cc69ea17a61edb80947cf969 ↗Source checked August 14, 2026
- Teriparatide and orthopedic surgery. · retained source version 1:2013-11-21:current:68c07c58229d1ffdf89283f5cbf2a0798a3e71b38fb61b87006c712b38b5a6de ↗Source checked August 14, 2026
- Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB. · retained source version 1:2026-08-13:current:8f7a6b5d5355ee9550f5bfbc0ea2400cfcf5d942402e5b481a5b34c92598d092 ↗Source checked August 14, 2026
- The glucagon/glucagon-like immunoreactivities in neurons of the human brain. · retained source version 1:2006-11-15:current:eb0ab12cd127f14a7ac7a13056023b42614a3fa5bc6afb653600a00c58586668 ↗Source checked August 14, 2026
- The role of leuprolide acetate therapy in triggering auto-immune thyroiditis. · retained source version 1:2013-11-21:current:11fe0a5a0ce3979597574872b629ff384e8a105d1a3e1a8aa3fc416ab47600cc ↗Source checked August 14, 2026
- Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation. · retained source version 1:2026-06-29:current:01df55bc35ba61dcdf88511fdbd5b239443c93fc0c78b7c86aa7f1e3e39caa6f ↗Source checked August 14, 2026
- Tirzepatide and Autonomic Dysfunction: Insights From Postural Orthostatic Tachycardia Syndrome. · retained source version 1:2026-08-13:current:aab8d817e70dc63edc2c3bc3681b41d4d4a5173d99c09ad0ea8ff381a2ec2096 ↗Source checked August 14, 2026
- Transarterial embolization combined with octreotide long-acting release in treating rectal neuroendocrine tumor liver metastases: a single-institutional experience. · retained source version 1:2026-08-13:current:06e297b8cda201ad477b5c8afbca6205fdf9a8379d0960360c74858ae263890b ↗Source checked August 14, 2026
- Treatment of obesity with liraglutide in bipolar disorder: a case report. · retained source version 1:2026-08-14:current:8b4f4fd804b3ae70a564195d7a0c065bcfa0d6d6e07a9d699602764f72d5b2bd ↗Source checked August 14, 2026
- UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation. · retained source version 1:2023-09-28:current:db7f6678955830dcf979c2ada0c8b15fb36e6f01b20f62a92673fcc5d4070320 ↗Source checked August 14, 2026
- Uptake of 18F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors. · retained source version 1:2026-08-13:current:3921f3ad04512f95397a601d413a1aa222210c0bb1a95642b464f8b136854e8e ↗Source checked August 14, 2026
- Ziconotide and psychosis: from a case report to a scoping review. · retained source version 1:2025-01-30:current:4d226faa94bb8c25a642b4029f8c60eb79c998e157106c88bf02084371f2818e ↗Source checked August 14, 2026
- [Acute pancreatitis in a patient treated with liraglutide]. · retained source version 1:2015-11-19:current:b466a0bccd6de52af29b161d3217c75ad1655d705b8927cc066f3e45d5233d76 ↗Source checked August 13, 2026
- [Advanced endometriosis treatment with leuprolide acetate]. · retained source version 1:2013-11-21:current:48b145b58064fa5e1964c405530fd790d5abf01bd4feb64092325a0db55b8410 ↗Source checked August 13, 2026
- [Behavior of glycemic answer to glucagon in the premature infant in the first months of life]. · retained source version 1:2006-03-28:current:5ab9bf82a448e2a467a19a2df9e106eeea7d498698862b98faca0b4e979aa53d ↗Source checked August 13, 2026
- [Blood level of glucagon in peptic ulcer]. · retained source version 1:2006-11-15:current:b5e4bc0d42dca458dd262350111c6885ba9dc39baa9fc3bbc7cd573f3beeae3e ↗Source checked August 13, 2026
- [Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit]. · retained source version 1:2006-03-28:current:adc62b2b9433cddc5372929e3171605aac234709777f41c70fa09d49151a04a3 ↗Source checked August 13, 2026
- [Case of type I glycogenosis. Considerations on its treatment with glucagon]. · retained source version 1:2006-03-28:current:1220e2f98377740bc1da3fe1241e8591ff8ef140af63c32f092bf9fb55ff8b43 ↗Source checked August 13, 2026
- [Circulating types of human glucagon (author's transl)]. · retained source version 1:2006-11-15:current:ce0475445f63cb7043c5e21860554c067da53063786c0121b82141811051597b ↗Source checked August 13, 2026
- [Clinical use of a GnRH analogue in a depot preparation (leuprolide acetate) in patients with surgical indication for uterine fibromyoma]. · retained source version 1:2013-11-21:current:a72c5d8cbc0ded78dda860997d63b78a44db8d53e181c460cbc71e1e95ea952a ↗Source checked August 13, 2026
- [Digestive fistula therapy with glucagon]. · retained source version 1:2004-11-17:current:e04681076c263699a3a5fa337399cf3e5e62c0ef3b84ca1b3494d437df2f61f3 ↗Source checked August 13, 2026
- [Drug treatment of acute esophageal varices hemorrhage using vasoactive substances (somatostatin and octreotide)]. · retained source version 1:2013-11-21:current:28fcecbe6abc28e0284969ad8db413a0085c98bb10439369471fd107a4c6467d ↗Source checked August 13, 2026
- [Experience in treatment of patients with neuropathic facial pain using ziconotide]. · retained source version 1:2026-01-28:current:9372c4860d25c3c380d29c095c61a7549ed28c5eae71b0ba8e0fd59bc3895fb9 ↗Source checked August 13, 2026
- [Exploration of glucide metabolism with the glucagon "test". Evaluation of the various methods of administration]. · retained source version 1:2005-11-17:current:84f80c746869b93fd19f64fb331a219a93cebfce37f2d11802f6d96f276eb7e3 ↗Source checked August 13, 2026
- [Glucagon and cardiogenic shock]. · retained source version 1:2004-11-17:current:c2baa2b7a8806475fb78643869e1bc0644cb1e3f3050eafe4c7839c827d7f554 ↗Source checked August 13, 2026
- [Glucagon and the gastrointestinal tract]. · retained source version 1:2004-11-17:current:54cf5e4e9eeccf5fe74d53e867bfb0a1a4f4acec19b21955d6b30ff0f1c500cb ↗Source checked August 13, 2026
- [Glucagon in cardiac insufficiency]. · retained source version 1:2004-11-17:current:36f8d75173d8225d02bf4855ae6c02aa12c6b33dc21709306b88cc6eff833725 ↗Source checked August 13, 2026
- [Glucagon in pediatrics. Exploration of carbohydrate metabolism in healthy children]. · retained source version 1:2005-11-17:current:5d6d8c8e45fbafc83713c1eca514fc38eee4d472197e3bab498806760173ffe3 ↗Source checked August 13, 2026
- [Glucagon in pediatrics. Exploration of glucide metabolism in sick children]. · retained source version 1:2005-11-17:current:9462c54027e091adea235563eeaf7f04f78d601c26833fbb9b2c764e769578af ↗Source checked August 13, 2026
- [Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane]. · retained source version 1:2006-11-15:current:956038b3e0e53aeb72d0697c18c1090b1e239d49677862d9d450ecb5a8a6c172 ↗Source checked August 13, 2026
- [Glucagon therapy of pancreatitis]. · retained source version 1:2004-11-17:current:2cf05841bd648e3b376db2bb174797ce05f2df6ff4c03d2d70f7bace00587e20 ↗Source checked August 13, 2026
- [Glucagon treatment and plasma kininogenesis in acute experimental pancreatitis (author's transl)]. · retained source version 1:2006-11-15:current:fb6e6fcbf8c3e85c73d7a5ffd6bcb5faf079920b23b1a07acc772c6637a5097c ↗Source checked August 13, 2026
- [Glucagon, the specific glycogenolytic hormone]. · retained source version 1:2004-11-17:current:1d745f6c9388bb2d5b30009a023319a2568f59291e83b5f6bb249bf9fd504330 ↗Source checked August 13, 2026
- [Glucagon: therapeutic uses and nursing implications]. · retained source version 1:2006-11-15:current:3e483f91add0ba90a7d79c611ac30957030899ef8d3da3d2b4698e56fbaa9a8c ↗Source checked August 13, 2026
- [Glucagon]. · retained source version 1:2004-11-17:current:2671767d3e6fa7e813e87baf7d22ed8df6dbafacee9bd0d8b1d9e2f1b967f327 ↗Source checked August 13, 2026
- [Glucagon]. · retained source version 1:2005-04-18:current:97c3a25a38ade73cd2eab9fe031353f52213b7803f8bb69873e163c3f524d358 ↗Source checked August 13, 2026
- [Has glucagon a value in the treatment of acute pancreatitis?]. · retained source version 1:2004-11-17:current:b51607ada2f342662cc4b079662af197f3c0046d6a9f6bde9d992f5f59309387 ↗Source checked August 13, 2026
- [Immunoreactive glucagon content of the pancreas of chick embryos and chicks]. · retained source version 1:2006-04-12:current:fbb69a46c116bb92bd5fd8d9bad6b69814a838773cfc67a13b27e45c8f4a6a55 ↗Source checked August 13, 2026
- [Insulinoma and octreotide]. · retained source version 1:2013-11-21:current:61b74fb41b83b8ae11ee57c9d8e2e40ff6d7cbd9ad5a954bc473d42cfb4f2164 ↗Source checked August 13, 2026
- [Isolation of glucagon from the chick pancreas using a macroporous ion exchanger]. · retained source version 1:2006-04-12:current:1f0e7fb4852478482bbcf0720cfffd6ad73b365cc5d06751be6c8150a72e8fce ↗Source checked August 13, 2026
- [Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration]. · retained source version 1:2019-10-26:current:363a279eed058fc6677fc7b80f7d31b9f47ec3bfadd2548d87a22be94db89092 ↗Source checked August 13, 2026
- [Lanreotide in the treatment of thyroid orbitopathy]. · retained source version 1:2016-11-24:current:5aa6edd1b8ced1b7081a988ecceac30ae1db1656dd7a9d1bc88c71acaa6434ac ↗Source checked August 13, 2026
- [Liraglutide in the treatment of diabetes type 2]. · retained source version 1:2015-11-19:current:3958cd82efe2e6a7fd0a2bbe05d386371cde63b9da5d0e8ce82659fc55a258cb ↗Source checked August 13, 2026
- [Liraglutide]. · retained source version 1:2015-11-19:current:c1791105c76ecdfdf08ef6cf97018db62aa1518b3bfb100cbf5cc4536b464073 ↗Source checked August 13, 2026
- [Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol]. · retained source version 1:2013-11-21:current:922ce937a83130fbba1502af2254d4fdbdf15c47a2247fed5ec80ab794e8521d ↗Source checked August 13, 2026
- [Myocardial contractility and metabolism under glucagon]. · retained source version 1:2004-11-17:current:500b79072550a1e469ba6b56cc25b3cd3e67605fcfa1f3eaf7abcb64e92eb0e3 ↗Source checked August 13, 2026
- [New findings on pancreatic glucagon in diabetes]. · retained source version 1:2004-11-17:current:2c3901baca95855ce603325bf9c038ec94f111dcb0f9dc4782393b2e1e1d3fa6 ↗Source checked August 13, 2026
- [New regulatory peptides in rat stomach secretion (amylin, PGP, semax)]. · retained source version 1:2018-11-30:current:1ee8ea7f51b4009b7f80e1b01d1a80295f0828ff0e329c6ee117ab6937f60296 ↗Source checked August 13, 2026
- [Octreotide and vascular headache]. · retained source version 1:2013-11-21:current:e3d9ccfbfef8117ef866e5d530c050efbff5601aaedad9614ae495b82d2d6ed2 ↗Source checked August 13, 2026
- [Octreotide in intestinal pseudo-obstruction?]. · retained source version 1:2013-11-21:current:f3576deab3d74aea19d59c43e18f761963318f8bb17215e1a85ee06c3003a9b9 ↗Source checked August 13, 2026
- [Octreotide: clinical experience]. · retained source version 1:2013-11-21:current:81fa9f17d5dba5465821e881ea37a54510d203c69d003af082bc37bdacf925c5 ↗Source checked August 13, 2026
- [On the mathematical analysis of hyperglycemia caused by glucagon evaluated as a liver function in the aged]. · retained source version 1:2004-11-17:current:a87984de346a52089d9b3196d83d8afa8fabdee85b4a60aa3f7f5e0e2fd40892 ↗Source checked August 13, 2026
- [On the physiological significance of glucagon in lipid metabolism]. · retained source version 1:2005-11-17:current:13bf0ed0c6b7182ad85d6284250015eec9cf46088a9d3df81bb2e2b5f9e002c4 ↗Source checked August 13, 2026
- [Possible use of octreotide in gastrointestinal pathology and in diabetes mellitus]. · retained source version 1:2013-11-21:current:5986c5c7de626319b85bb917b2bcdd4dbcaf7b20f56d10cc8bdcc1d61d2eef30 ↗Source checked August 13, 2026
- [Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases]. · retained source version 1:2019-10-27:current:e8863db4055ade76b5ad4dc90efb3c3651aa80eb13c547a8b464a3f2dd28b83b ↗Source checked August 13, 2026
- [Reactive hypoglycemia and intestinal glucagon]. · retained source version 1:2004-11-17:current:6fa8cd962d5de7799134a60fc3d56caf22f8573a8daba6a5dd15be0a7176b2f0 ↗Source checked August 13, 2026
- [Recent advances in studies on glucagon]. · retained source version 1:2004-11-17:current:c763a548fe73b939b5553f57ec86b123077c4181828b512b0651391b73f2adae ↗Source checked August 13, 2026
- [Recent studies on the physiology of glucagon]. · retained source version 1:2004-11-17:current:9a0fb6fd6dd527788939eada47633f9f079974b1820dc8bc822da0482d313765 ↗Source checked August 13, 2026
- [Recommendations for the management of chronic pain by intrathecal ziconotide]. · retained source version 1:2026-01-28:current:39c8065ef5d3b8c40a6a45fdec7b30c5e109f12d6d60046d64c0123f70b8bfc7 ↗Source checked August 13, 2026
- [Research on carbohydrate metabolism in thymectomized rats. VI. Behavior of sensitivity to glucagon]. · retained source version 1:2005-11-17:current:edfcef8f2ba7e9fbf03b5bb793e6f879a0951c3cfaea94fad29c76e2d0b0b96d ↗Source checked August 13, 2026
- [Role of glucagon in diabetes]. · retained source version 1:2004-11-17:current:55ac88a25dad2417c895252cf2af73f4893ef46955704b622c777b02f754a645 ↗Source checked August 13, 2026
- [Role of glucagon in pathophysiology (author's transl)]. · retained source version 1:2006-11-15:current:804dae5de2d42ae6a9c464b7e79807ec36833cacb411b183ab7b07d268cf91ec ↗Source checked August 13, 2026
- [Role of glucagon in the treatment of acute pancreatitis]. · retained source version 1:2006-11-15:current:082beed8b05216648b0daf8c8d059576fbed5d563a6dc639592ab6ea79b16d12 ↗Source checked August 13, 2026
- [Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes]. · retained source version 1:2026-01-28:current:6b325eeb5482ca234d241acf97c384a3f88361d4b89a98b901dd9a6864f3a320 ↗Source checked August 13, 2026
- [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis]. · retained source version 1:2013-11-21:current:b3357144e898710557df9a0e549882ccdd0fa72a330a4608bffede9dba9467a9 ↗Source checked August 13, 2026
- [Somatostatin and octreotide in therapy of gastrointestinal diseases]. · retained source version 1:2013-11-21:current:8a19c828227ab3175aa38f2a98b1a15791ca26dd7d109792065f6dfaf19813b8 ↗Source checked August 13, 2026
- [Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients]. · retained source version 1:2016-11-24:current:270de4f82007e9e9aa2a6bfbc26aae2ad1b2b3cfef7893bb3030174c3c8232a0 ↗Source checked August 13, 2026
- [Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis]. · retained source version 1:2013-11-21:current:83eebfdbbdcc8565d2b8ba515596dd85aed57c94019e5f7bc710d5b187a17fda ↗Source checked August 13, 2026
- [The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation]. · retained source version 1:2019-10-26:current:338c7ebe209f061713717edf9bb899123b352af6f31a7e69fab5788fcddc47d9 ↗Source checked August 13, 2026
- [The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters]. · retained source version 1:2026-01-28:current:31afee16a5824fbd33eee0647b8c80717425ad150ec35a3e9277cf163bee5cf5 ↗Source checked August 13, 2026
- [The role of glucagon in child's body]. · retained source version 1:2004-11-17:current:c0acd2203aa013cd5fa36f62a9afbbe5478d150432ba934ee3445ddadb361477 ↗Source checked August 13, 2026
- [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium]. · retained source version 1:2013-11-21:current:6b5a3f4263511ea8e8c12cf4b3d8915b4caa7d3f74530b049c33a02767238eeb ↗Source checked August 13, 2026
- [Treatment of pseudocyst in chronic pancreatitis by puncture-drainage and octreotide combination]. · retained source version 1:2013-11-21:current:3f54f4857299d762768443cc224de0d25da6f8cd319513a739617bf0d5e94469 ↗Source checked August 13, 2026
- ▼Abaloparatide (Eladynos) for osteoporosis. · retained source version 1:2025-09-11:current:9a8831c827ce9a09c441fc4c5892c437f6a3e79f7208e6fc1e0a41aeb9bc83eb ↗Source checked August 13, 2026
- 100 years of glucagon and 100 more. · retained source version 1:2026-07-26:current:77637f01663e4526fe362b061bd14c21814e273989e0d883a7ba054a5501b66a ↗Source checked August 13, 2026
- A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE. · retained source version 1:2020-11-05:current:2fd9820446e2bee78fd7c42d0ce0d2d3d6bd719b75e95f279321a37762834646 ↗Source checked August 13, 2026
- A case of multiple type I endocrine neoplasia with gastrin-producing and glucagon-producing tumors successfully resected 18 years after insulinoma surgery. · retained source version 1:2026-07-14:current:367d6f86b2d1bb21cb9694872b2a7d023d0d6719e62ad8fdf3840c667882850d ↗Source checked August 13, 2026
- A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. · retained source version 1:2026-01-27:current:aa0c3498cce656b4c069137f7d3d13b3b097c75d989b1fb12ce62aa03c5db4e3 ↗Source checked August 13, 2026
- A comprehensive analysis of community pharmacists' practices, barriers, and strategies in patient education on Saxenda®: a qualitative study. · retained source version 1:2026-06-27:current:a8bf5b9b9f34f5c8f29da1ceaca0e3d9ed9d32b915a50f35c9911a885a1f5aaa ↗Source checked August 13, 2026
- A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026. · retained source version 1:2026-07-14:current:61052405099deb295acba3bc90321721298307fc56408b44128064001d13e1c3 ↗Source checked August 13, 2026
- A phase II study of leuprolide in advanced/recurrent endometrial cancer. · retained source version 1:2013-11-21:current:d245a72c68285a8a7baed582e1ba5641855eff1aaf78f888759d24d411412bad ↗Source checked August 13, 2026
- A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. · retained source version 1:2026-01-28:current:6983cb4bd2ed2fe7663e758e7c42a6aa519c03211b95cf6b0dd5789198a7ca3d ↗Source checked August 13, 2026
- A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome. · retained source version 1:2020-06-15:current:40a8e79c0d452f9547d06101e342f82a962e9b773d493f01f4ed9329c05af526 ↗Source checked August 13, 2026
- A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c. · retained source version 1:2025-10-01:current:2730295d9fca474e1e86d3b6a7818857e13310a098599881cc6313cb6051fdc3 ↗Source checked August 13, 2026
- A randomized comparison of intranasal and injectable octreotide administration in patients with acromegaly. · retained source version 1:2013-11-21:current:65e1d6d873f624ae4a3a414eccafcc06450254fb79e5974a2e8b832d3f4ac9b4 ↗Source checked August 13, 2026
- A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. · retained source version 1:2024-08-01:current:2de27befa715b62f9d131c1f5e2925f1252d023bb34e809baa79a7b2c7acb59b ↗Source checked August 13, 2026
- A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation. · retained source version 1:2022-04-08:current:9ef724a102b0ee35a2c3b85c6ae867e595e4f4e5afc273e2aa9bb8d9b9440ef5 ↗Source checked August 13, 2026
- A simple mechanistic model for insulin-glucose-glucagon dynamics and its implications for diabetes management. · retained source version 1:2026-07-14:current:d56f9edc63f7082d5d77de0b2dbb3260762ec99ef44d6766df27d1d529599542 ↗Source checked August 13, 2026
- Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend. · retained source version 1:2021-06-02:current:e4337230734991453b318d7c5bbf1b1ebfb2976b469500c37a00c78355a67f78 ↗Source checked August 13, 2026
- Abaloparatide Real-World Patient Experience Study. · retained source version 1:2021-03-30:current:951f8ae1283eff3af0ca47104ad81ab12cf661211168394edc09d1a2de7504cf ↗Source checked August 13, 2026
- Abaloparatide: a new anabolic therapy on the horizon. · retained source version 1:2022-03-09:current:526e04574c420a20b3f41b1d39b683cb45e4425e19ae99d90daaa9082580b766 ↗Source checked August 13, 2026
- Abaloparatide: First Global Approval. · retained source version 1:2026-01-27:current:176244bcd04ad856ddcb9708bf3d18b7b4660fb21f55eaff74a921d6e1eaeda7 ↗Source checked August 13, 2026
- Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy. · retained source version 1:2026-01-28:current:d37f462ac60c597bf972c0bca39018f911d8846023c28717b587f9580f08b70a ↗Source checked August 13, 2026
- Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide. · retained source version 1:2024-03-12:current:73fa9764a20798cd9cbd453bf574f187db4ad0deb543059c5fdfc2319cc759a6 ↗Source checked August 13, 2026
- Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 Solution. · retained source version 1:2025-06-29:current:4adebe5f1537baa6961a00ca318a484b8804c0c6758c2004702fa04e3983e736 ↗Source checked August 13, 2026
- Acute interstitial nephritis after treatment with liraglutide. · retained source version 1:2015-11-19:current:b3cb6ccec2a4e3d3e43a9f6774c982a35d9b131b16442c42fa837b2cc4dc1573 ↗Source checked August 13, 2026
- Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide. · retained source version 1:2021-12-06:current:840683304345ee4ff8f54dc7c9416749e24b5dd4a6d47c7be83eed392190d538 ↗Source checked August 13, 2026
- Acute rhabdomyolysis in a patient with long-term exposure to intrathecal ziconotide: a case report. · retained source version 1:2018-12-02:current:78e16dcdc93fd927a40c0f124c5697a4817b2338d030d057f1ecce036f5c777a ↗Source checked August 13, 2026
- Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. · retained source version 1:2026-01-28:current:fa251b343ad891312060e741d73844c29f7b0dc686f7f3b1e840747757874074 ↗Source checked August 13, 2026
- Advances in the management of erythropoietic protoporphyria - role of afamelanotide. · retained source version 1:2023-11-11:current:afc0bd25e3bfe0c83a9a98a61df1bf5d5581e57a7b0fe39d6123ae61744ffbc5 ↗Source checked August 13, 2026
- Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians. · retained source version 1:2022-12-07:current:841da48362e9af56bded2ea00310c32ce28cb8a011b70644a72fb1cb14c7caec ↗Source checked August 13, 2026
- Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective. · retained source version 1:2025-10-27:current:38c5d53310863af3e8e10264961443dffed6fb3354711c49badf9531200e7d33 ↗Source checked August 13, 2026
- Afamelanotide in protoporphyria and other skin diseases: a review. · retained source version 1:2024-05-25:current:0f82149add463ff814c90307eab1349daa04be75a6198619c0fa281ebd9c5e5c ↗Source checked August 13, 2026
- Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations. · retained source version 1:2026-07-20:current:e63a85694fb5e6363b4b7ad35adb80e27ad87a19012f948ee5599e18fc6090e1 ↗Source checked August 13, 2026
- Amyloidogenesis of the amylin analogue pramlintide. · retained source version 1:2019-12-10:current:58e631e24d529c3177ec1325eeae8b36f77a2f55bbeb2d5ce405bbcd74b93ef9 ↗Source checked August 13, 2026
- An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. · retained source version 1:2023-01-17:current:e635a689e632def4788202d749b9f01a2ab1e24b7d5601125d9bf4de25e8b6dd ↗Source checked August 13, 2026
- An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials. · retained source version 1:2026-01-28:current:f13eb769169ecaff2e102ebff7f8baae47ad35356ae50f4223e8fdfd256c15b5 ↗Source checked August 13, 2026
- Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats. · retained source version 1:2026-06-04:current:d7efec2d77ce1a57e4ca9be2bccc87105908333fff9733dda63847a8d0c6ffc0 ↗Source checked August 13, 2026
- Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? · retained source version 1:2025-05-21:current:290a48099613e79a6d8c7608a58371884ef3f09f6d7b513a247fb184f7df2e5f ↗Source checked August 13, 2026
- Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy. · retained source version 1:2026-01-28:current:189f530b1df3d6c06b25f2d313ede762997a3fb8e7e743845fed7f22720ce172 ↗Source checked August 13, 2026
- Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. · retained source version 1:2013-11-21:current:06409f495e5c20a4275f69f644399557499514913401325102c92e93e8e100bd ↗Source checked August 13, 2026
- Audiogenic epilepsy in young mice of different strains after neonatal semax treatment. · retained source version 1:2019-08-13:current:be9d73330bfdde9be2d37c481904e920a4669384a00dcf28060ee54721f69cd6 ↗Source checked August 13, 2026
- Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study. · retained source version 1:2021-01-09:current:12fd34f9e46dd89177530955d8da23046910dd009f9a9525fea7956ae10e9ab1 ↗Source checked August 13, 2026
- Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. · retained source version 1:2026-07-10:current:fa03fbbeb8bd051c19fee899331a07ff6c40320343154ba67107bf893a9edb4a ↗Source checked August 13, 2026
- Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. · retained source version 1:2025-01-03:current:628404c7fcb96bf4b9797b5cfda9d78acda3083d570ad69a5a2404240b889574 ↗Source checked August 13, 2026
- Biodegradable Nanoflowers with Abaloparatide Spatiotemporal Management of Functional Alveolar Bone Regeneration. · retained source version 1:2025-07-29:current:2edc72b2026ed913d8d730ee0dc4d71577c6aa187a3361e57bea8a9c912e158c ↗Source checked August 13, 2026
- Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State. · retained source version 1:2026-07-01:current:88f56341ed1294272ab32ea3a3c258c536254fbf533ba6ec400eef7b447f7b77 ↗Source checked August 13, 2026
- Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7). · retained source version 1:2020-05-29:current:1c7854c801b85a2d6efcac8400f97f59d891b78cb8dd4221d078c139ceccb7e1 ↗Source checked August 13, 2026
- Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage. · retained source version 1:2026-06-10:current:c8d2102ecbb13f8924f34e34b242109b5ca59f5cd003224deac90fb0ead716b7 ↗Source checked August 13, 2026
- BPC 157 and blood vessels. · retained source version 1:2019-07-28:current:06578a8fd26b7fe378575933d57fafc366db474da7dba44e1b4f05ae1eb7dbf3 ↗Source checked August 13, 2026
- BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias. · retained source version 1:2017-11-16:current:861016b292b3b41ed04ca263edc8e44a56f7d04d58d268442c13a09ba25b1b46 ↗Source checked August 13, 2026
- Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. · retained source version 1:2019-11-13:current:6f14c37e2e6d53c931c0c6dd78bc1b31b64ce9e4728fc6a8689ae2d9212b1f8b ↗Source checked August 13, 2026
- Bremelanotide for Treatment of Female Hypoactive Sexual Desire. · retained source version 1:2022-01-28:current:306c02855c39b8a144562a49bc686e6f30ce22e7aeaf77363a541befd80ba0a0 ↗Source checked August 13, 2026
- Can androgen deprivation with leuprolide be predicted from histology alone? If not, why not? · retained source version 1:2013-11-21:current:b89bda76954b9bd540fdf9388f65030f2adc27d836765e6b0b81c8844bf92671 ↗Source checked August 13, 2026
- Can Intermittent Teriparatide Facilitate Supraphysiological-Rate Distraction Osteogenesis? A Feasibility Study in the Rabbit Tibial Lengthening Model. · retained source version 1:2026-05-28:current:e4be8bfed5868780fd4f6ec3f4ae613b95442941a50938979db4eda1359b20ee ↗Source checked August 13, 2026
- Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it. · retained source version 1:2026-06-29:current:6b0d19232bf2cb7bac16217fccab8b0e92ea721271146662626c21d172d03874 ↗Source checked August 13, 2026
- Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity? · retained source version 1:2026-07-02:current:3eabe701c1e1d1e9133c3307bc6c006152a5047bc7c27e3849a6e87dbe0b73d5 ↗Source checked August 13, 2026
- Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors. · retained source version 1:2025-11-19:current:868fff9ba5dac266e6c60097c2efbec0c71892b5b786288efdac53400582dee1 ↗Source checked August 13, 2026
- Central MOTS-c infusion affects reproductive hormones in obese and non-obese rats. · retained source version 1:2024-04-01:current:5232216ceee830e822999daa77c3b3ad9a8ad8bfe9c131998222da11274b0071 ↗Source checked August 13, 2026
- Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. · retained source version 1:2026-07-12:current:52000ff1efbec556a2f29cded665122b740a254d664e7d9ab706c19f9735d7f6 ↗Source checked August 13, 2026
- Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS. · retained source version 1:2026-01-27:current:1250dc49dffa5130d87d577cd04d1737803d113e0ec13801f6317ec64b38205f ↗Source checked August 13, 2026
- Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). · retained source version 1:2006-11-15:current:dc972720fc3178fb9c2a4f47be00d79d65b6b96ae2a0ff5f1ebba1a56dea4cdc ↗Source checked August 13, 2026
- Circadian variation of DSIP-like material in rat plasma. · retained source version 1:2019-07-01:current:1c60cfcdd72e676a0baeb4c405f48041b3bcf6b1e5b1f122cae38de7faf11b62 ↗Source checked August 13, 2026
- Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study. · retained source version 1:2023-02-28:current:24b6a0107acc2ed16dd0f3fa587f87cb983bf9ac96dd923b4bdda8f4a36d5654 ↗Source checked August 13, 2026
- Circulating levels of MOTS-c in patients with breast cancer treated with metformin. · retained source version 1:2026-01-27:current:957110a704a564c1275e53531614c9d2b86c7e6c966efa2612b4155e9a3eb338 ↗Source checked August 13, 2026
- Clarification of linaclotide clinical trial information in a recent review on constipation. · retained source version 1:2018-12-02:current:5f9bafd3fe8c84c703a322e9a64f3eb623df1ae5ca2fde8d9c4f984091f7c8ee ↗Source checked August 13, 2026
- Clarification of trial end points presented in a recent review of linaclotide. · retained source version 1:2018-12-01:current:b2b7d1063c8d1206b8c9f3f4a0b2cd9d40655bb667f0276366aa6ceecf498122 ↗Source checked August 13, 2026
- Clinical experience with exenatide in a routine secondary care diabetes clinic. · retained source version 1:2026-01-28:current:481d7b86467c23bd88c7976b3045d357fecaa031e8e7844f45065d7213c299eb ↗Source checked August 13, 2026
- Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes. · retained source version 1:2026-01-28:current:a87fc8d4c0baa9b4f8f784f8200f53c3f7c4fc347addd2fcd5580620d09afaed ↗Source checked August 13, 2026
- Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus. · retained source version 1:2026-01-28:current:fdde71a7649a1e8bc2a077f249cc29070823950a8de8b4d8960898257e4d5f99 ↗Source checked August 13, 2026
- Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy. · retained source version 1:2015-11-19:current:c9e08ae18400076736e5728ca858ed27de28df2c784180ba210c9261903a801c ↗Source checked August 13, 2026
- Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study. · retained source version 1:2026-04-30:current:9a3b7f34f72ae55a13b9d614daf28e593d472ad01713bf8234b958ee2d57ad5d ↗Source checked August 13, 2026
- Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial. · retained source version 1:2026-08-13:current:0e06086c0a136f12f9bda58fdf47cf9c839c1a040d1922d2f4520623be36dcbf ↗Source checked August 13, 2026
- Comparative study of analgesic potency of ACTH4-10 fragment and its analog semax. · retained source version 1:2019-08-13:current:4ff59acc9f8894ad7eaa5da95c1449f0a574b255dcca00bc99f8fd733b30b4e3 ↗Source checked August 13, 2026
- Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analysis. · retained source version 1:2021-03-11:current:7452eedf35fdd99847e07c9f4c6dd02073fe2ae10d60fc7c3f739fe290f936b7 ↗Source checked August 13, 2026
- Comparison between capillary electrophoresis and fluorescence anisotropy competitive immunoassay for glucagon. · retained source version 1:2026-07-20:current:276a93316239cd9c67516bdb7ba2cea1f377d715e200ea4719bc5cea9334392c ↗Source checked August 13, 2026
- Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy. · retained source version 1:2026-01-28:current:629863bb85d8032a9c1436928a15ec9f6730c0928d8fc669a8525b2be0a76df2 ↗Source checked August 13, 2026
- Composition of Colon Microbiota in Rats Treated with ACTH(4-7)-PGP Peptide (Semax) under Conditions of Restraint Stress. · retained source version 1:2021-06-07:current:66897f71938af5fa88598dd24984bd24a6835c0c3205a269688d212e39d098fc ↗Source checked August 13, 2026
- Comprehensive design and characterization of pH-gradient-loaded donkey-milk exosomes for oral octreotide delivery: A bench-to-in silico roadmap. · retained source version 1:2026-07-11:current:78a24974583407a5a1719915af7add679e9f4cefba746f019dafa8053bba2730 ↗Source checked August 13, 2026
- Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study. · retained source version 1:2023-05-22:current:502cc3c3cdd1b02975408a6a37541b69f2c1124087ecd4220c5cf269bfa55ebb ↗Source checked August 13, 2026
- Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia. · retained source version 1:2024-07-29:current:fbf69723d51b93112877d253f8aae12790eb06b499f879739d6cefd533399615 ↗Source checked August 13, 2026
- Considerations and methodology for trialing ziconotide. · retained source version 1:2026-01-28:current:686b80a1bb63a496aa0c96ee4ff8255da34d1295f46b7dd9f20235ed7f5fc13b ↗Source checked August 13, 2026